###begin article-title 0
MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers
###end article-title 0
###begin p 1
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 171 175 171 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 224 228 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 313 317 313 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
*Data used in the preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. ADNI investigators include (complete listing available at ).
###end p 1
###begin p 2
###xml 0 16 0 16 <!--CREATIVE COMMONS-->
CREATIVE COMMONSThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License () which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 2
###begin p 3
###xml 707 711 701 705 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 1260 1264 1245 1249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 1898 1902 1874 1878 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 871 879 <span type="species:ncbi:9606">patients</span>
###xml 1606 1614 <span type="species:ncbi:9606">patients</span>
Hippocampal volume change over time, measured with MRI, has huge potential as a marker for Alzheimer's disease. The objectives of this study were: (i) to test if constant and accelerated hippocampal loss can be detected in Alzheimer's disease, mild cognitive impairment and normal ageing over short periods, e.g. 6-12 months, with MRI in the large multicentre setting of the Alzheimer's Disease Neuroimaging Initiative (ADNI); (ii) to determine the extent to which the polymorphism of the apolipoprotein E (ApoE) gene modulates hippocampal change; and (iii) to determine if rates of hippocampal loss correlate with cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease, such as the beta-amyloid (Abeta1-42) and tau proteins (tau). The MRI multicentre study included 112 cognitive normal elderly individuals, 226 mild cognitive impairment and 96 Alzheimer's disease patients who all had at least three successive MRI scans, involving 47 different imaging centres. The mild cognitive impairment and Alzheimer's disease groups showed hippocampal volume loss over 6 months and accelerated loss over 1 year. Moreover, increased rates of hippocampal loss were associated with presence of the ApoE allele epsilon4 gene in Alzheimer's disease and lower CSF Abeta1-42 in mild cognitive impairment, irrespective of ApoE genotype, whereas relations with tau were only trends. The power to measure hippocampal change was improved by exploiting correlations statistically between successive MRI observations. The demonstration of considerable hippocampal loss in mild cognitive impairment and Alzheimer's disease patients over only 6 months and accelerated loss over 12 months illustrates the power of MRI to track morphological brain changes over time in a large multisite setting. Furthermore, the relations between faster hippocampal loss in the presence of ApoE allele epsilon4 and decreased CSF Abeta1-42 supports the concept that increased hippocampal loss is an indicator of Alzheimer's disease pathology and a potential marker for the efficacy of therapeutic interventions in Alzheimer's disease.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 156 162 156 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 164 168 164 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">2005</xref>
###xml 631 635 631 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">1998</xref>
###xml 692 699 692 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in-vivo</italic>
###xml 710 716 710 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 718 722 718 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B49">2007</xref>
Alzheimer's disease is the most common cause of dementia and a growing health problem globally, affecting 20% of the population over 80 years of age (Ferri et al., 2005). Currently, the definite diagnosis of Alzheimer's disease can only be made through autopsy to find the pathological hallmarks of the disease, microscopic amyloid plaques and neurofibrillary tangles. The development of biomarkers that can reliably indicate presence of the disease at the earliest possible stage is therefore an important public health goal. Macroscopically, Alzheimer's disease is associated with progressive brain tissue loss (Braak and Braak, 1998), which MRI can non-invasively visualize to some extent in-vivo (Thompson et al., 2007). Not surprisingly, MRI has attracted considerable interest as a tool to identify Alzheimer's disease biomarkers.
###end p 5
###begin p 6
###xml 207 211 207 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">1998</xref>
###xml 459 465 459 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 467 471 467 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">2000</xref>
###xml 477 478 477 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 473 478 473 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">2008<italic>b</italic></xref>
###xml 483 489 483 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 491 495 491 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">2004</xref>
###xml 502 508 502 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 510 514 510 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">2004</xref>
###xml 520 526 520 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 528 532 528 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">2005</xref>
###xml 544 550 544 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 552 556 552 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">2005</xref>
###xml 569 575 569 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 577 581 577 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">2005</xref>
###xml 734 740 734 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 742 746 742 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">2005</xref>
###xml 759 765 759 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 767 771 767 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">2007</xref>
###xml 998 1004 992 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1006 1010 1000 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">2000</xref>
###xml 1020 1026 1014 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1032 1033 1026 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 1028 1033 1022 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">2008<italic>b</italic></xref>
###xml 1046 1052 1040 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1054 1058 1048 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">2007</xref>
###xml 1234 1240 1228 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1242 1246 1236 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">2003</xref>
###xml 1256 1262 1250 1256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1264 1268 1258 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">2008</xref>
###xml 1312 1318 1306 1312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1320 1324 1314 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">2006</xref>
###xml 1331 1337 1325 1331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1343 1344 1337 1338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 1339 1344 1333 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">2008<italic>c</italic></xref>
###xml 1760 1764 1751 1755 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 1811 1817 1802 1808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1819 1823 1810 1814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">2008</xref>
###xml 2029 2035 2020 2026 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2037 2041 2028 2032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">2003</xref>
###xml 2047 2048 2038 2039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 1360 1368 <span type="species:ncbi:9606">patients</span>
Histological studies have shown that the hippocampus is particularly vulnerable to Alzheimer's disease pathology and already considerably damaged at the time clinical symptoms first appear (Braak and Braak, 1998). The hippocampus has therefore become a primary target of MRI studies in Alzheimer's disease. In agreement with histological findings, longitudinal MRI studies have shown increased rates of hippocampal volume loss in Alzheimer's disease (Jack Jr et al., 2000, 2008b; Du et al., 2004; Jack et al., 2004; Fox et al., 2005; Hashimoto et al., 2005; van de Pol et al., 2005) and mild cognitive impairment (MCI, a transitional stage to Alzheimer's disease that may define a window for effective therapeutic intervention) (Jack et al., 2005; van de Pol et al., 2007), in comparison to normal ageing. Several MRI studies also found that the apolipoprotein E gene allele epsilon4 (ApoE4), a major risk factor for Alzheimer's disease, is associated with higher rates of hippocampal loss (Moffat et al., 2000; Jack Jr et al., 2008b; van de Pol et al., 2007), though the mechanism behind the ApoE4 induced variations remains obscure. Longitudinal MRI studies at multiple time-points further indicate that brain loss in general (Chan et al., 2003; Carlson et al., 2008) and hippocampus loss in particular (Ridha et al., 2006; Jack et al., 2008c) accelerate in patients with MCI and Alzheimer's disease though the specific trajectory of change remains unknown. To link MRI observations of hippocampal loss more firmly to the presence of Alzheimer's disease pathology, there has also been growing interest in using MRI together with biochemical markers of Alzheimer's disease in CSF, such as the proteins of tau (indicative of tangle formation) and amyloid Abeta1-42 (a major component of amyloid plaques) (Clark et al., 2008). Lastly, clinical trials of Alzheimer's disease and mild cognitive impairment have used the progression of hippocampal loss as a potential surrogate for the efficacy of therapeutic interventions (Jack Jr et al., 2003, 2008b).
###end p 6
###begin p 7
###xml 349 355 349 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 361 362 361 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 1368 1374 1368 1374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1376 1380 1376 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">2005</xref>
###xml 1390 1396 1390 1396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1398 1402 1398 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">2006</xref>
###xml 1410 1416 1410 1416 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1418 1422 1418 1422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">2008</xref>
Despite many promising results, several technical issues in measuring hippocampal disease progression remain unresolved, such as data variability due to non-uniform acquisition and image restoration processing. In this study, MRI was performed using uniform imaging sequences and a centralized setup for quality control and image restorations (Jack et al., 2008a). Furthermore, the vast majority of longitudinal MRI studies were carried out over a period of at least 1 year or much longer to ensure that the accumulated hippocampal loss exceeded the incurred measurement errors. Most studies were also performed at a single site to avoid site-to-site variations in MRI. However, studies over a long period at a single research centre represent a 'best-case' scenario, which can rarely be achieved in large studies, such as clinical trials, involving several hundred subjects. The power of MRI to measure hippocampal loss, especially acceleration, over short periods and in a multisite setting remains to be determined. Another issue is that many MRI investigations of biological effects on hippocampal change involved only a small number of subjects, especially those which involved CSF biomarkers, raising concerns about the generalization of the findings. Lastly, few studies so far reported findings of hippocampal changes, ApoE and CSF biomarkers together (Hampel et al., 2005; de Leon et al., 2006; Fjell et al., 2008). Although it was found that CSF biomarker levels and the ApoE profile are associated with morphometric changes in the hippocampus, the extent to which each factor independently contributes to the progression of hippocampal changes has not been investigated.
###end p 7
###begin p 8
###xml 57 61 57 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 120 126 120 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 455 459 455 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 350 358 <span type="species:ncbi:9606">patients</span>
The ongoing Alzheimer's disease Neuroimaging Initiative (ADNI) study has been designed to address these issues (Mueller et al., 2005) (see also  and ). The ADNI is a large multisite longitudinal MRI and FDG-PET (fluorodeoxyglucose positron emission tomography) study of 200 cognitively normal (normal) elderly controls, 400 subjects with MCI and 200 patients diagnosed with Alzheimer's disease. At the time of writing this report, data collection for the ADNI project is still in progress. Here, we report an initial analysis of rates of hippocampal loss in 498 subjects, who completed three successive MRI scans and clinical evaluations at baseline, 6 and 12 months, involving 47 MRI sites.
###end p 8
###begin p 9
###xml 91 95 91 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
Our main objectives in this study were: first, to determine if the rigorous methods of the ADNI to control site-to-site variations in MRI allow the detection of hippocampal change, including acceleration, over a short period, e.g. 6-12 months; second, to determine the extent to which the ApoE genotype modulates rates of hippocampal loss; and third, to test if rates of hippocampal loss correlate with CSF biomarkers.
###end p 9
###begin title 10
Methods
###end title 10
###begin p 11
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 407 411 407 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 1028 1032 1028 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
Data used in the preparation of this article were obtained from the ADNI database (). The ADNI was launched in 2003 by the National Institute on Aging (NIA), the National Institute of Biomedical Imaging and Bioengineering (NIBIB), the Food and Drug Administration (FDA), private pharmaceutical companies and non-profit organizations, as a $60 million, 5-year public-private partnership. The primary goal of ADNI has been to test whether serial MRI, positron emission tomography (PET), other biological markers and clinical and neuropsychological assessment can be combined to measure the progression of MCI and early Alzheimer's disease. Determination of sensitive and specific markers of very early Alzheimer's disease progression is intended to aid researchers and clinicians to develop new treatments and monitor their effectiveness, as well as lessen the time and cost of clinical trials. The Principle Investigator of this initiative is Michael W. Weiner, MD, VA Medical Center and University of California, San Francisco. ADNI is the result of efforts of many co-investigators from a broad range of academic institutions and private corporations, and subjects have been recruited from over 50 sites across the US and Canada. For up-to-date information see .
###end p 11
###begin title 12
Subjects
###end title 12
###begin p 13
###xml 762 769 762 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 834 842 834 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Br Med J</italic>
###xml 959 966 959 966 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 1</label>
###xml 966 1014 966 1014 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="14">Group demographics and clinical data at baseline</p>
###xml 966 1014 966 1014 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="14">Group demographics and clinical data at baseline</p></caption>
###xml 1014 1022 1014 1022 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Measures</th>
###xml 1022 1028 1022 1028 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Normal</th>
###xml 1028 1053 1028 1053 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Mild cognitive impairment</th>
###xml 1053 1072 1053 1072 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Alzheimer's disease</th>
###xml 1072 1073 1072 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1072 1079 1072 1079 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>P</italic>-value</th>
###xml 1014 1079 1014 1079 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Measures</th><th rowspan="1" colspan="1">Normal</th><th rowspan="1" colspan="1">Mild cognitive impairment</th><th rowspan="1" colspan="1">Alzheimer's disease</th><th rowspan="1" colspan="1"><italic>P</italic>-value</th></tr>
###xml 1014 1079 1014 1079 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Measures</th><th rowspan="1" colspan="1">Normal</th><th rowspan="1" colspan="1">Mild cognitive impairment</th><th rowspan="1" colspan="1">Alzheimer's disease</th><th rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead>
###xml 1079 1080 1079 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1079 1080 1079 1080 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"><italic>n</italic></td>
###xml 1080 1083 1080 1083 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">127</td>
###xml 1083 1086 1083 1086 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">226</td>
###xml 1086 1088 1086 1088 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">96</td>
###xml 1088 1090 1088 1090 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NA</td>
###xml 1079 1090 1079 1090 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1"><italic>n</italic></td><td rowspan="1" colspan="1">127</td><td rowspan="1" colspan="1">226</td><td rowspan="1" colspan="1">96</td><td rowspan="1" colspan="1">NA</td></tr>
###xml 1090 1099 1090 1099 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Women (%)</td>
###xml 1099 1101 1099 1101 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">48</td>
###xml 1101 1103 1101 1103 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">38</td>
###xml 1103 1105 1103 1105 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">47</td>
###xml 1105 1107 1105 1107 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NS</td>
###xml 1090 1107 1090 1107 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">Women (%)</td><td rowspan="1" colspan="1">48</td><td rowspan="1" colspan="1">38</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">NS</td></tr>
###xml 1107 1118 1107 1118 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Age (years)</td>
###xml 1118 1130 1118 1128 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">76.3 &#177; 5.1</td>
###xml 1130 1142 1128 1138 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">75.0 &#177; 7.1</td>
###xml 1142 1154 1138 1148 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">75.8 &#177; 6.6</td>
###xml 1154 1156 1148 1150 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">NS</td>
###xml 1107 1156 1107 1150 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">76.3 &#177; 5.1</td><td rowspan="1" colspan="1">75.0 &#177; 7.1</td><td rowspan="1" colspan="1">75.8 &#177; 6.6</td><td rowspan="1" colspan="1">NS</td></tr>
###xml 1160 1161 1154 1155 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 1160 1161 1154 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF1"><sup>a</sup></xref>
###xml 1156 1161 1150 1155 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MMSE<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td>
###xml 1161 1173 1155 1165 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">29.1 &#177; 0.9</td>
###xml 1173 1185 1165 1175 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">26.9 &#177; 1.8</td>
###xml 1185 1197 1175 1185 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">23.3 &#177; 1.9</td>
###xml 1197 1203 1185 1191 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&lt;0.001</td>
###xml 1156 1203 1150 1191 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">MMSE<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">29.1 &#177; 0.9</td><td rowspan="1" colspan="1">26.9 &#177; 1.8</td><td rowspan="1" colspan="1">23.3 &#177; 1.9</td><td rowspan="1" colspan="1">&lt;0.001</td></tr>
###xml 1211 1212 1199 1200 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 1211 1212 1199 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF2"><sup>b</sup></xref>
###xml 1203 1212 1191 1200 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ADAS-Cog<xref ref-type="table-fn" rid="TF2"><sup>b</sup></xref></td>
###xml 1212 1223 1200 1209 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">6.1 &#177; 3.3</td>
###xml 1223 1235 1209 1219 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">11.6 &#177; 4.5</td>
###xml 1235 1247 1219 1229 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">17.9 &#177; 5.6</td>
###xml 1247 1253 1229 1235 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&lt;0.001</td>
###xml 1203 1253 1191 1235 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">ADAS-Cog<xref ref-type="table-fn" rid="TF2"><sup>b</sup></xref></td><td rowspan="1" colspan="1">6.1 &#177; 3.3</td><td rowspan="1" colspan="1">11.6 &#177; 4.5</td><td rowspan="1" colspan="1">17.9 &#177; 5.6</td><td rowspan="1" colspan="1">&lt;0.001</td></tr>
###xml 1269 1270 1251 1252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 1269 1270 1251 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF3"><sup>c</sup></xref>
###xml 1253 1270 1235 1252 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">CDR Sum-of-boxes<xref ref-type="table-fn" rid="TF3"><sup>c</sup></xref></td>
###xml 1270 1279 1252 1259 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0 &#177; 0.1</td>
###xml 1279 1290 1259 1268 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.6 &#177; 0.9</td>
###xml 1290 1301 1268 1277 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">4.4 &#177; 1.5</td>
###xml 1301 1307 1277 1283 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&lt;0.001</td>
###xml 1253 1307 1235 1283 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">CDR Sum-of-boxes<xref ref-type="table-fn" rid="TF3"><sup>c</sup></xref></td><td rowspan="1" colspan="1">0 &#177; 0.1</td><td rowspan="1" colspan="1">1.6 &#177; 0.9</td><td rowspan="1" colspan="1">4.4 &#177; 1.5</td><td rowspan="1" colspan="1">&lt;0.001</td></tr>
###xml 1310 1311 1286 1287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 1310 1311 1286 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF4"><sup>d</sup></xref>
###xml 1307 1311 1283 1287 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">GDS<xref ref-type="table-fn" rid="TF4"><sup>d</sup></xref></td>
###xml 1311 1322 1287 1296 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0.8 &#177; 1.3</td>
###xml 1322 1333 1296 1305 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.5 &#177; 1.3</td>
###xml 1333 1344 1305 1314 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1.7 &#177; 1.4</td>
###xml 1350 1351 1320 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF5">*</xref>
###xml 1344 1351 1314 1321 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&lt;0.001<xref ref-type="table-fn" rid="TF5">*</xref></td>
###xml 1307 1351 1283 1321 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">GDS<xref ref-type="table-fn" rid="TF4"><sup>d</sup></xref></td><td rowspan="1" colspan="1">0.8 &#177; 1.3</td><td rowspan="1" colspan="1">1.5 &#177; 1.3</td><td rowspan="1" colspan="1">1.7 &#177; 1.4</td><td rowspan="1" colspan="1">&lt;0.001<xref ref-type="table-fn" rid="TF5">*</xref></td></tr>
###xml 1351 1369 1321 1339 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ApoE4 carriers (%)</td>
###xml 1369 1371 1339 1341 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">26</td>
###xml 1371 1373 1341 1343 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">52</td>
###xml 1373 1375 1343 1345 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">67</td>
###xml 1375 1381 1345 1351 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&lt;0.001</td>
###xml 1351 1381 1321 1351 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">ApoE4 carriers (%)</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">52</td><td rowspan="1" colspan="1">67</td><td rowspan="1" colspan="1">&lt;0.001</td></tr>
###xml 1079 1381 1079 1351 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1"><italic>n</italic></td><td rowspan="1" colspan="1">127</td><td rowspan="1" colspan="1">226</td><td rowspan="1" colspan="1">96</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1">Women (%)</td><td rowspan="1" colspan="1">48</td><td rowspan="1" colspan="1">38</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">76.3 &#177; 5.1</td><td rowspan="1" colspan="1">75.0 &#177; 7.1</td><td rowspan="1" colspan="1">75.8 &#177; 6.6</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">MMSE<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">29.1 &#177; 0.9</td><td rowspan="1" colspan="1">26.9 &#177; 1.8</td><td rowspan="1" colspan="1">23.3 &#177; 1.9</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">ADAS-Cog<xref ref-type="table-fn" rid="TF2"><sup>b</sup></xref></td><td rowspan="1" colspan="1">6.1 &#177; 3.3</td><td rowspan="1" colspan="1">11.6 &#177; 4.5</td><td rowspan="1" colspan="1">17.9 &#177; 5.6</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">CDR Sum-of-boxes<xref ref-type="table-fn" rid="TF3"><sup>c</sup></xref></td><td rowspan="1" colspan="1">0 &#177; 0.1</td><td rowspan="1" colspan="1">1.6 &#177; 0.9</td><td rowspan="1" colspan="1">4.4 &#177; 1.5</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">GDS<xref ref-type="table-fn" rid="TF4"><sup>d</sup></xref></td><td rowspan="1" colspan="1">0.8 &#177; 1.3</td><td rowspan="1" colspan="1">1.5 &#177; 1.3</td><td rowspan="1" colspan="1">1.7 &#177; 1.4</td><td rowspan="1" colspan="1">&lt;0.001<xref ref-type="table-fn" rid="TF5">*</xref></td></tr><tr><td rowspan="1" colspan="1">ApoE4 carriers (%)</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">52</td><td rowspan="1" colspan="1">67</td><td rowspan="1" colspan="1">&lt;0.001</td></tr></tbody>
###xml 1014 1381 1014 1351 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Measures</th><th rowspan="1" colspan="1">Normal</th><th rowspan="1" colspan="1">Mild cognitive impairment</th><th rowspan="1" colspan="1">Alzheimer's disease</th><th rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1"><italic>n</italic></td><td rowspan="1" colspan="1">127</td><td rowspan="1" colspan="1">226</td><td rowspan="1" colspan="1">96</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1">Women (%)</td><td rowspan="1" colspan="1">48</td><td rowspan="1" colspan="1">38</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">76.3 &#177; 5.1</td><td rowspan="1" colspan="1">75.0 &#177; 7.1</td><td rowspan="1" colspan="1">75.8 &#177; 6.6</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">MMSE<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">29.1 &#177; 0.9</td><td rowspan="1" colspan="1">26.9 &#177; 1.8</td><td rowspan="1" colspan="1">23.3 &#177; 1.9</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">ADAS-Cog<xref ref-type="table-fn" rid="TF2"><sup>b</sup></xref></td><td rowspan="1" colspan="1">6.1 &#177; 3.3</td><td rowspan="1" colspan="1">11.6 &#177; 4.5</td><td rowspan="1" colspan="1">17.9 &#177; 5.6</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">CDR Sum-of-boxes<xref ref-type="table-fn" rid="TF3"><sup>c</sup></xref></td><td rowspan="1" colspan="1">0 &#177; 0.1</td><td rowspan="1" colspan="1">1.6 &#177; 0.9</td><td rowspan="1" colspan="1">4.4 &#177; 1.5</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">GDS<xref ref-type="table-fn" rid="TF4"><sup>d</sup></xref></td><td rowspan="1" colspan="1">0.8 &#177; 1.3</td><td rowspan="1" colspan="1">1.5 &#177; 1.3</td><td rowspan="1" colspan="1">1.7 &#177; 1.4</td><td rowspan="1" colspan="1">&lt;0.001<xref ref-type="table-fn" rid="TF5">*</xref></td></tr><tr><td rowspan="1" colspan="1">ApoE4 carriers (%)</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">52</td><td rowspan="1" colspan="1">67</td><td rowspan="1" colspan="1">&lt;0.001</td></tr></tbody></table>
###xml 1381 1432 1351 1402 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="15">a Mini-Mental State Examination; range 0&#8211;30 points.</p>
###xml 1381 1432 1351 1402 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF1"><p textid="15">a Mini-Mental State Examination; range 0&#8211;30 points.</p></fn>
###xml 1432 1509 1402 1479 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="16">b Alzheimer's disease Assessment Scale&#8212;Cognitive Subscale; range 0&#8211;70 points.</p>
###xml 1432 1509 1402 1479 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF2"><p textid="16">b Alzheimer's disease Assessment Scale&#8212;Cognitive Subscale; range 0&#8211;70 points.</p></fn>
###xml 1509 1561 1479 1531 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="17">c Clinical Dementia Rating Scale; range 0&#8211;18 points.</p>
###xml 1509 1561 1479 1531 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF3"><p textid="17">c Clinical Dementia Rating Scale; range 0&#8211;18 points.</p></fn>
###xml 1561 1609 1531 1579 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="18">d Geriatric Depression Scale; range 0&#8211;15 points.</p>
###xml 1561 1609 1531 1579 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF4"><p textid="18">d Geriatric Depression Scale; range 0&#8211;15 points.</p></fn>
###xml 1609 1715 1579 1685 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="19">*Significant difference in GDS scores between normal and mild cognitive impairment or Alzheimer's disease.</p>
###xml 1609 1715 1579 1685 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF5"><p textid="19">*Significant difference in GDS scores between normal and mild cognitive impairment or Alzheimer's disease.</p></fn>
###xml 1381 1715 1351 1685 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><fn id="TF1"><p textid="15">a Mini-Mental State Examination; range 0&#8211;30 points.</p></fn><fn id="TF2"><p textid="16">b Alzheimer's disease Assessment Scale&#8212;Cognitive Subscale; range 0&#8211;70 points.</p></fn><fn id="TF3"><p textid="17">c Clinical Dementia Rating Scale; range 0&#8211;18 points.</p></fn><fn id="TF4"><p textid="18">d Geriatric Depression Scale; range 0&#8211;15 points.</p></fn><fn id="TF5"><p textid="19">*Significant difference in GDS scores between normal and mild cognitive impairment or Alzheimer's disease.</p></fn></table-wrap-foot>
###xml 959 1715 959 1685 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T1" position="float"><label>Table 1</label><caption><p textid="14">Group demographics and clinical data at baseline</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Measures</th><th rowspan="1" colspan="1">Normal</th><th rowspan="1" colspan="1">Mild cognitive impairment</th><th rowspan="1" colspan="1">Alzheimer's disease</th><th rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1"><italic>n</italic></td><td rowspan="1" colspan="1">127</td><td rowspan="1" colspan="1">226</td><td rowspan="1" colspan="1">96</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1">Women (%)</td><td rowspan="1" colspan="1">48</td><td rowspan="1" colspan="1">38</td><td rowspan="1" colspan="1">47</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">Age (years)</td><td rowspan="1" colspan="1">76.3 &#177; 5.1</td><td rowspan="1" colspan="1">75.0 &#177; 7.1</td><td rowspan="1" colspan="1">75.8 &#177; 6.6</td><td rowspan="1" colspan="1">NS</td></tr><tr><td rowspan="1" colspan="1">MMSE<xref ref-type="table-fn" rid="TF1"><sup>a</sup></xref></td><td rowspan="1" colspan="1">29.1 &#177; 0.9</td><td rowspan="1" colspan="1">26.9 &#177; 1.8</td><td rowspan="1" colspan="1">23.3 &#177; 1.9</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">ADAS-Cog<xref ref-type="table-fn" rid="TF2"><sup>b</sup></xref></td><td rowspan="1" colspan="1">6.1 &#177; 3.3</td><td rowspan="1" colspan="1">11.6 &#177; 4.5</td><td rowspan="1" colspan="1">17.9 &#177; 5.6</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">CDR Sum-of-boxes<xref ref-type="table-fn" rid="TF3"><sup>c</sup></xref></td><td rowspan="1" colspan="1">0 &#177; 0.1</td><td rowspan="1" colspan="1">1.6 &#177; 0.9</td><td rowspan="1" colspan="1">4.4 &#177; 1.5</td><td rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td rowspan="1" colspan="1">GDS<xref ref-type="table-fn" rid="TF4"><sup>d</sup></xref></td><td rowspan="1" colspan="1">0.8 &#177; 1.3</td><td rowspan="1" colspan="1">1.5 &#177; 1.3</td><td rowspan="1" colspan="1">1.7 &#177; 1.4</td><td rowspan="1" colspan="1">&lt;0.001<xref ref-type="table-fn" rid="TF5">*</xref></td></tr><tr><td rowspan="1" colspan="1">ApoE4 carriers (%)</td><td rowspan="1" colspan="1">26</td><td rowspan="1" colspan="1">52</td><td rowspan="1" colspan="1">67</td><td rowspan="1" colspan="1">&lt;0.001</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p textid="15">a Mini-Mental State Examination; range 0&#8211;30 points.</p></fn><fn id="TF2"><p textid="16">b Alzheimer's disease Assessment Scale&#8212;Cognitive Subscale; range 0&#8211;70 points.</p></fn><fn id="TF3"><p textid="17">c Clinical Dementia Rating Scale; range 0&#8211;18 points.</p></fn><fn id="TF4"><p textid="18">d Geriatric Depression Scale; range 0&#8211;15 points.</p></fn><fn id="TF5"><p textid="19">*Significant difference in GDS scores between normal and mild cognitive impairment or Alzheimer's disease.</p></fn></table-wrap-foot></table-wrap>
The study reported here involved 498 subjects who had MRI scans at baseline, 6 and 12 months (0-6-12 m) and hippocampal volume change measured. Of those subjects, 11 were excluded because they had lumbar puncture procedures within <10 days prior to their MRI (a protocol violation), which may have induced artificial volume changes of the brain. The MRI data of an additional 38 subjects were excluded for technical reasons, such as major hardware upgrades during the study (at two sites), miscalibration of image resolution or failure to register images to a brain template for tracing the hippocampus. At the end, 127 normal, 226 MCI and 96 Alzheimer's disease subjects were considered. The main demographical and clinical data of this group are summarized in Table 1. Consent was obtained according to the Declaration of Helsinki (Br Med J 1991; 302: 1194) and the Ethical Committees of each Institution in which the work was performed approved the study. Table 1Group demographics and clinical data at baselineMeasuresNormalMild cognitive impairmentAlzheimer's diseaseP-valuen12722696NAWomen (%)483847NSAge (years)76.3 +/- 5.175.0 +/- 7.175.8 +/- 6.6NSMMSEa29.1 +/- 0.926.9 +/- 1.823.3 +/- 1.9<0.001ADAS-Cogb6.1 +/- 3.311.6 +/- 4.517.9 +/- 5.6<0.001CDR Sum-of-boxesc0 +/- 0.11.6 +/- 0.94.4 +/- 1.5<0.001GDSd0.8 +/- 1.31.5 +/- 1.31.7 +/- 1.4<0.001*ApoE4 carriers (%)265267<0.001a Mini-Mental State Examination; range 0-30 points.b Alzheimer's disease Assessment Scale-Cognitive Subscale; range 0-70 points.c Clinical Dementia Rating Scale; range 0-18 points.d Geriatric Depression Scale; range 0-15 points.*Significant difference in GDS scores between normal and mild cognitive impairment or Alzheimer's disease.
###end p 13
###begin p 14
Group demographics and clinical data at baseline
###end p 14
###begin p 15
a Mini-Mental State Examination; range 0-30 points.
###end p 15
###begin p 16
b Alzheimer's disease Assessment Scale-Cognitive Subscale; range 0-70 points.
###end p 16
###begin p 17
c Clinical Dementia Rating Scale; range 0-18 points.
###end p 17
###begin p 18
d Geriatric Depression Scale; range 0-15 points.
###end p 18
###begin p 19
*Significant difference in GDS scores between normal and mild cognitive impairment or Alzheimer's disease.
###end p 19
###begin p 20
###xml 208 214 208 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 216 220 216 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">1975</xref>
###xml 350 356 350 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 358 362 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">1997</xref>
###xml 550 554 550 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">1993</xref>
###xml 701 707 701 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 709 713 709 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">1982</xref>
###xml 889 893 889 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
All subjects underwent thorough clinical and cognitive assessments at the time of each of their MRI scans. Each subject's cognitive evaluation included: (i) the Mini-Mental State Examination (MMSE) (Folstein et al., 1975) to provide a global measure of mental status; (ii) the Alzheimer's disease Assessment Scale-Cognitive Subscale (ADAS-Cog) (Mohs et al., 1997), which is the most used cognitive assessment battery in clinical dementia trials; and (iii) the Clinical Dementia Rating (CDR) sum-of-boxes scale (sum of individual CDR scales) (Morris, 1993) to stage severity of dementia. All subjects were also examined for depression using the Geriatric Depression Scale (GDS) questionnaire (Yesavage et al., 1982), in which subjects are asked to respond to 30-items with 'yes' or 'no' in reference to how they felt over the past week. More details about all the tests can be found on the ADNI website .
###end p 20
###begin p 21
###xml 496 502 480 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 504 508 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">1984</xref>
###xml 419 427 <span type="species:ncbi:9606">patients</span>
###xml 682 690 <span type="species:ncbi:9606">patients</span>
The normal subjects had on average MMSE scores of 29.1 +/- 0.9, ADAS-Cog scores of 6.1 +/- 3.3, CDR sum of boxes scores of 0 +/- 0.1 and GDS scores of 0.8 +/- 1.3. The MCI subjects had mild memory complaints, but had no symptoms of dementia. On average, they had MMSE scores of 26.9 +/- 1.8, ADAS-Cog scores of 11.6 +/- 4.5, CDR sum of boxes scores of 1.6 +/- 0.9 and GDS scores of 1.5 +/- 1.3. All Alzheimer's disease patients met NINCDS/ADRDA criteria for probable Alzheimer's disease (McKhann et al., 1984). On average, they had MMSE scores of 23.3 +/- 1.9 and ADAS-Cog scores of 17.9 +/- 5.6, CDR sum of boxes scores of 4.4 +/- 1.5 and GDS scores of 1.7 +/- 1.3. As such, these patients would be considered as having mild to moderate, but not severe Alzheimer's disease and no depression.
###end p 21
###begin p 22
###xml 302 306 302 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 629 633 623 627 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 679 685 673 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 687 691 681 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">2007</xref>
###xml 708 714 702 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 716 720 710 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">2008</xref>
###xml 727 733 721 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 735 739 729 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">2009</xref>
All subjects had their blood ApoE genotype determined. In addition, two-third of the subjects had lumbar puncture procedures performed for the collection of specific Alzheimer's disease biomarkers. The determinations of ApoE and biomarkers were performed by Drs Leslie Shaw and John Trojanowski of the ADNI Biomarker Core at the University of Pennsylvania School of Medicine, which collects and banks biological samples (DNA, blood, urine and CSF) from all participating sites, and conducts studies of selected Alzheimer's disease biomarkers, including total tau (t-tau), hyperphosphorylated tau (p-tau), beta-amyloid-1-42 (Abeta1-42), isoprostanes and homocysteine levels (Shaw et al., 2007; Vanderstichele et al., 2008; Shaw et al., 2009) (see for more details).
###end p 22
###begin p 23
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
Detailed exclusion criteria, e.g. regarding concomitant cerebral vascular disease or concurrent use of psychoactive medications, can be found in the ADNI protocol (page 29, ). Briefly, subjects were excluded if they had any significant neurological disease other than incipient Alzheimer's disease, any history of significant brain lesions or head trauma, or psychoactive medication use (including antidepressants, neuroleptics, chronic anxiolytics or sedative hypnotics, etc.).
###end p 23
###begin title 24
MRI acquisition and pre-processing
###end title 24
###begin p 25
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 185 186 185 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 238 244 238 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 250 251 250 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 390 396 390 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 398 402 398 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">2006</xref>
###xml 409 415 409 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 421 422 421 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 457 458 457 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 757 758 751 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 761 762 755 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 768 769 762 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">z</italic>
###xml 836 840 830 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 995 1001 989 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1007 1008 1001 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 1003 1008 997 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">2008<italic>b</italic></xref>
###xml 1267 1271 1261 1265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 1563 1567 1557 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 1606 1612 1600 1606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1618 1619 1612 1613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 875 879 <span type="species:ncbi:162683">Mayo</span>
###xml 1722 1726 <span type="species:ncbi:162683">Mayo</span>
All subjects had MRI at 1.5T. The data were collected at multiple ADNI sites using a standardized MRI protocol (), which was developed after a major effort evaluating and comparing 3D T1-weighted sequences for morphometric analyses (Jack et al., 2008a). In this study, the MRI data came from 47 centres. Details of MRI acquisition and processing are described in several publications (Leow et al., 2006; Jack et al., 2008a). Briefly, for each subject, two T1-weighted MRI scans were collected using a sagittal volumetric magnetization prepared rapid gradient echo (3D MP-RAGE) sequence with the following acquisition parameters: echo time (TE) of 4 ms, repetition time (TR) of 9 ms, flip angle of 8degrees, acquisition matrix size of 256 x 256 x 166 in the x-, y- and z-dimensions with a nominal voxel size of 0.94 x 0.94 x 1.2 mm. The ADNI MRI quality control centre at the Mayo Clinic (Rochester, MN, USA) selected the MP-RAGE image with higher quality based on standardized criteria (Jack Jr et al., 2008b). To enhance the standardization across MRI sites and scanner platforms, each site used the same customized imaging sequence for volumetric brain morphometry, which was developed and tested on phantoms and on 137 subjects during the preparation phase of the ADNI study. Second, each subject scan was accompanied by a scan of a custom built phantom that was centrally evaluated for signal-to-noise and geometrical fidelity to ensure performance of the MRI scanners remained within a specific tolerance limit. More details about MRI standardization in the ADNI study can be found in reference (Jack et al., 2008a). Furthermore, system specific corrections of certain image artefacts were performed centrally at the Mayo Clinic. The corrections included: (i) a 'B1-Field correction' to adjust for inhomogeneity of image intensity induced by non-uniform radiofrequency (RF) excitation using B1 calibration scans, (ii) 'N3 bias field correction' to further reduce intensity inhomogeneity caused by non-uniform sensitivity of the receiver coils, (iii) a geometrical distortion correction to offset non-linearity in frequency encoding of magnetic field gradients and (iv) global geometrical scaling, based on phantom measurements that accompanied every subject's MRI scan to adjust for gradient calibration errors and drifts.
###end p 25
###begin title 26
Hippocampal volume estimation
###end title 26
###begin p 27
###xml 201 207 201 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 209 213 209 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">1997</xref>
###xml 1266 1272 1266 1272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1274 1278 1274 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">2002</xref>
###xml 1252 1260 <span type="species:ncbi:9606">patients</span>
Tracing of the anatomical boundaries of the left and right hippocampus was performed using a semi-automated brain mapping method based on a high-dimensional fluid transformation algorithm (Christensen et al., 1997), which combines a coarse and then a fine transformation of a carefully marked hippocampal MRI template from a reference brain to match the target images of each subject. A commercially available version of the algorithm was used (Medtronic Surgical Navigation Technologies, Louisville, CO). To guide the initial transformations, 22 control points are manually placed as rough local landmarks for hippocampal segmentation: one point at the hippocampal head, one at the tail, and four per image (i.e. at the superior, inferior, medial and lateral boundaries) on five equally spaced image slices perpendicular to the long axis of the ipsilateral hippocampus. The last step is repeated for the contralateral hippocampus. Using the landmarks for initial guidance, automated hippocampal segmentation is then performed by the iterative fluid transformation image matching algorithm. The procedure has previously been validated for hippocampal volume measurements in elderly subjects, including mild cognitive impairment and Alzheimer's disease patients (Hsu et al., 2002).
###end p 27
###begin p 28
To minimize measurement variability and bias from manually placing the landmarks, a comprehensive procedure for assessing reader reliability was implemented. First, the readers were extensively trained and their reliability was evaluated by having each reader perform twice volume measurements of a 'gold standard' MRI dataset that consisted of 10 randomly selected subjects. To qualify, a reader had to achieve an intraclass correlation coefficient of at least 0.9 for both within and between reader consistencies. Furthermore, reliability of readings was monitored over time by blindly having each reader re-evaluate randomly selected sets from the 'gold-standard' sets as data processing progressed. The re-evaluations had to be within the 95% confidence limits to qualify. If a reader's performance dropped outside the limits, the last hippocampal markings by this reader were re-processed by a qualified reader. In addition, the disqualified reader had to complete training again to qualify.
###end p 28
###begin title 29
Statistics
###end title 29
###begin p 30
###xml 945 946 945 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
We employed a general linear mixed effects model for analysis of the longitudinal data in which the response variable (e.g. hippocampal volume or ADAS-Cog score) is regressed against the explanatory variable (time) separately from within subject correlations. To investigate the benefits of collecting data at more than two time-points, we extended the model by a transitional (i.e. Markov chain) model, in which past observations explicitly influence present measurements. More details are provided in the appendix. Other explanatory variables, e.g. diagnosis, age or ApoE4 profile, were added into the model as appropriate. To determine if the addition of explanatory variables, especially the inclusion of past observations in the Markov chain model, improved explanatory power, we designed paired models (with and without the additional explanatory variable), fitted the models by maximum likelihood (ML) and compared the resulting fits via F-tests. The level of significance was 0.05 for all tests.
###end p 30
###begin p 31
###xml 137 143 <span type="species:ncbi:9606">person</span>
###xml 363 371 <span type="species:ncbi:9606">patients</span>
To assess site-to-site variations in the MRI data, we bootstrapped the random effects residuals of the fits (i.e. the unexplained within-person variation and noise) and evaluated differences between the MRI centres by analysis of variance. To reduce the influence of group heterogeneity between centres, we first limited the analysis to mild cognitive impairment patients, which was usually the group with the most completed scans at each centre and second, we augmented bootstrapping by permutation tests.
###end p 31
###begin p 32
Sample size calculations for the number of subjects needed in a hypothetical clinical trial of measuring a meaningful drug effect (i.e. slowing of rates of hippocampal loss or change in ADAS-Cog scores) between a treated and placebo group are outlined in the appendix. All statistical calculations were conducted using R (the R Project for Statistical Computing; ).
###end p 32
###begin title 33
Results
###end title 33
###begin title 34
Data at baseline
###end title 34
###begin p 35
###xml 77 84 77 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 121 122 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 152 153 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 167 168 165 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 246 247 244 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 347 348 345 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 427 428 425 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 581 582 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 598 599 594 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 710 717 706 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 849 850 845 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 912 913 908 909 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 990 991 986 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1015 1022 1011 1018 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 2</label>
###xml 1022 1117 1018 1113 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="36">Hippocampal baseline volumes and rates of volume loss by group for different MRI scan intervals</p>
###xml 1022 1117 1018 1113 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="36">Hippocampal baseline volumes and rates of volume loss by group for different MRI scan intervals</p></caption>
###xml 1117 1117 1113 1113 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1117 1123 1113 1119 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Normal</th>
###xml 1123 1148 1119 1144 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Mild cognitive impairment</th>
###xml 1148 1167 1144 1163 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Alzheimer's disease</th>
###xml 1117 1167 1113 1163 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Normal</th><th rowspan="1" colspan="1">Mild cognitive impairment</th><th rowspan="1" colspan="1">Alzheimer's disease</th></tr>
###xml 1117 1167 1113 1163 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Normal</th><th rowspan="1" colspan="1">Mild cognitive impairment</th><th rowspan="1" colspan="1">Alzheimer's disease</th></tr></thead>
###xml 1179 1180 1175 1176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1167 1181 1163 1177 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Baseline [mm<sup>3</sup>]</td>
###xml 1181 1198 1177 1192 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">2133 &#177; 25 (279)</td>
###xml 1198 1215 1192 1207 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1846 &#177; 23 (348)</td>
###xml 1215 1232 1207 1222 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1631 &#177; 34 (330)</td>
###xml 1167 1232 1163 1222 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">Baseline [mm<sup>3</sup>]</td><td rowspan="1" colspan="1">2133 &#177; 25 (279)</td><td rowspan="1" colspan="1">1846 &#177; 23 (348)</td><td rowspan="1" colspan="1">1631 &#177; 34 (330)</td></tr>
###xml 1241 1242 1231 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1232 1248 1222 1238 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Rates [mm<sup>3</sup>/year]</td>
###xml 1248 1248 1238 1238 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1248 1248 1238 1238 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1248 1248 1238 1238 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1232 1248 1222 1238 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">Rates [mm<sup>3</sup>/year]</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 1248 1257 1238 1247 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0&#8211;6 month</td>
###xml 1257 1288 1247 1276 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;19.7 &#177; 17.0 [&#8211;89 to 51] (74)</td>
###xml 1302 1303 1288 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF8">*</xref>
###xml 1288 1321 1276 1307 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;37.7 &#177; 10.6<xref ref-type="table-fn" rid="TF8">*</xref> [&#8211;144 to 74] (63)</td>
###xml 1335 1336 1319 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF8">*</xref>
###xml 1321 1354 1307 1338 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8211;53.5 &#177; 15.6<xref ref-type="table-fn" rid="TF8">*</xref> [&#8211;152 to 62] (59)</td>
###xml 1248 1354 1238 1338 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">0&#8211;6 month</td><td rowspan="1" colspan="1">&#8722;19.7 &#177; 17.0 [&#8211;89 to 51] (74)</td><td rowspan="1" colspan="1">&#8211;37.7 &#177; 10.6<xref ref-type="table-fn" rid="TF8">*</xref> [&#8211;144 to 74] (63)</td><td rowspan="1" colspan="1">&#8211;53.5 &#177; 15.6<xref ref-type="table-fn" rid="TF8">*</xref> [&#8211;152 to 62] (59)</td></tr>
###xml 1354 1364 1338 1348 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">6&#8211;12 month</td>
###xml 1364 1395 1348 1377 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;8.3 &#177; 21.7 [&#8722;105 to 78] (85)</td>
###xml 1409 1410 1389 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF8">*</xref>
###xml 1395 1428 1377 1408 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;54.2 &#177; 11.8<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;242 to 82] (60)</td>
###xml 1442 1443 1420 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF8">*</xref>
###xml 1428 1461 1408 1439 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;91.3 &#177; 18.2<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;207 to 63] (62)</td>
###xml 1354 1461 1338 1439 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">6&#8211;12 month</td><td rowspan="1" colspan="1">&#8722;8.3 &#177; 21.7 [&#8722;105 to 78] (85)</td><td rowspan="1" colspan="1">&#8722;54.2 &#177; 11.8<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;242 to 82] (60)</td><td rowspan="1" colspan="1">&#8722;91.3 &#177; 18.2<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;207 to 63] (62)</td></tr>
###xml 1471 1472 1449 1450 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 1471 1472 1449 1450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF6"><sup>a</sup></xref>
###xml 1461 1472 1439 1450 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">6&#8211;12 month<xref ref-type="table-fn" rid="TF6"><sup>a</sup></xref></td>
###xml 1472 1490 1450 1466 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;6.7 &#177; 18.1 (74)</td>
###xml 1503 1504 1477 1478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF8">*</xref>
###xml 1490 1509 1466 1483 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;56.1 &#177; 9.8<xref ref-type="table-fn" rid="TF8">*</xref> (53)</td>
###xml 1523 1524 1495 1496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF8">*</xref>
###xml 1509 1529 1483 1501 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;93.0 &#177; 15.0<xref ref-type="table-fn" rid="TF8">*</xref> (50)</td>
###xml 1461 1529 1439 1501 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">6&#8211;12 month<xref ref-type="table-fn" rid="TF6"><sup>a</sup></xref></td><td rowspan="1" colspan="1">&#8722;6.7 &#177; 18.1 (74)</td><td rowspan="1" colspan="1">&#8722;56.1 &#177; 9.8<xref ref-type="table-fn" rid="TF8">*</xref> (53)</td><td rowspan="1" colspan="1">&#8722;93.0 &#177; 15.0<xref ref-type="table-fn" rid="TF8">*</xref> (50)</td></tr>
###xml 1529 1539 1501 1511 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0&#8211;12 month</td>
###xml 1553 1554 1523 1524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 1553 1554 1523 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF8"><sup>#</sup></xref>
###xml 1539 1571 1511 1541 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;17.3 &#177; 10.5<xref ref-type="table-fn" rid="TF8"><sup>#</sup></xref> [&#8722;97 to 53] (80)</td>
###xml 1584 1585 1552 1553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF8">*</xref>
###xml 1571 1603 1541 1571 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;47.5 &#177; 6.5<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;153 to 79] (65)</td>
###xml 1616 1617 1582 1583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF8">*</xref>
###xml 1603 1635 1571 1601 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;72.0 &#177; 9.0<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;162 to 50] (56)</td>
###xml 1529 1635 1501 1601 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">0&#8211;12 month</td><td rowspan="1" colspan="1">&#8722;17.3 &#177; 10.5<xref ref-type="table-fn" rid="TF8"><sup>#</sup></xref> [&#8722;97 to 53] (80)</td><td rowspan="1" colspan="1">&#8722;47.5 &#177; 6.5<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;153 to 79] (65)</td><td rowspan="1" colspan="1">&#8722;72.0 &#177; 9.0<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;162 to 50] (56)</td></tr>
###xml 1654 1655 1620 1621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 1654 1655 1620 1621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF7"><sup>b</sup></xref>
###xml 1635 1655 1601 1621 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Percent change/year<xref ref-type="table-fn" rid="TF7"><sup>b</sup></xref></td>
###xml 1655 1655 1621 1621 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1655 1655 1621 1621 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1655 1655 1621 1621 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 1635 1655 1601 1621 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">Percent change/year<xref ref-type="table-fn" rid="TF7"><sup>b</sup></xref></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 1655 1664 1621 1630 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0&#8211;6 month</td>
###xml 1664 1676 1630 1640 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;0.9 &#177; 0.8</td>
###xml 1688 1689 1650 1651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF8">*</xref>
###xml 1676 1689 1640 1651 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;2.0 &#177; 0.6<xref ref-type="table-fn" rid="TF8">*</xref></td>
###xml 1701 1702 1661 1662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF8">*</xref>
###xml 1689 1702 1651 1662 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;3.3 &#177; 0.9<xref ref-type="table-fn" rid="TF8">*</xref></td>
###xml 1655 1702 1621 1662 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">0&#8211;6 month</td><td rowspan="1" colspan="1">&#8722;0.9 &#177; 0.8</td><td rowspan="1" colspan="1">&#8722;2.0 &#177; 0.6<xref ref-type="table-fn" rid="TF8">*</xref></td><td rowspan="1" colspan="1">&#8722;3.3 &#177; 0.9<xref ref-type="table-fn" rid="TF8">*</xref></td></tr>
###xml 1702 1712 1662 1672 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">6&#8211;12 month</td>
###xml 1712 1724 1672 1682 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;0.4 &#177; 1.0</td>
###xml 1736 1737 1692 1693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF8">*</xref>
###xml 1724 1737 1682 1693 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;2.9 &#177; 0.6<xref ref-type="table-fn" rid="TF8">*</xref></td>
###xml 1749 1750 1703 1704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF8">*</xref>
###xml 1737 1750 1693 1704 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;5.6 &#177; 1.1<xref ref-type="table-fn" rid="TF8">*</xref></td>
###xml 1702 1750 1662 1704 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">6&#8211;12 month</td><td rowspan="1" colspan="1">&#8722;0.4 &#177; 1.0</td><td rowspan="1" colspan="1">&#8722;2.9 &#177; 0.6<xref ref-type="table-fn" rid="TF8">*</xref></td><td rowspan="1" colspan="1">&#8722;5.6 &#177; 1.1<xref ref-type="table-fn" rid="TF8">*</xref></td></tr>
###xml 1760 1761 1714 1715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 1760 1761 1714 1715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF6"><sup>a</sup></xref>
###xml 1750 1761 1704 1715 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">6&#8211;12 month<xref ref-type="table-fn" rid="TF6"><sup>a</sup></xref></td>
###xml 1761 1773 1715 1725 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;0.3 &#177; 0.8</td>
###xml 1785 1786 1735 1736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF8">*</xref>
###xml 1773 1786 1725 1736 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;3.0 &#177; 0.5<xref ref-type="table-fn" rid="TF8">*</xref></td>
###xml 1798 1799 1746 1747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF8">*</xref>
###xml 1786 1799 1736 1747 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;5.7 &#177; 0.9<xref ref-type="table-fn" rid="TF8">*</xref></td>
###xml 1750 1799 1704 1747 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">6&#8211;12 month<xref ref-type="table-fn" rid="TF6"><sup>a</sup></xref></td><td rowspan="1" colspan="1">&#8722;0.3 &#177; 0.8</td><td rowspan="1" colspan="1">&#8722;3.0 &#177; 0.5<xref ref-type="table-fn" rid="TF8">*</xref></td><td rowspan="1" colspan="1">&#8722;5.7 &#177; 0.9<xref ref-type="table-fn" rid="TF8">*</xref></td></tr>
###xml 1799 1809 1747 1757 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">0&#8211;12 month</td>
###xml 1821 1822 1767 1768 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 1821 1822 1767 1768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF8"><sup>#</sup></xref>
###xml 1809 1822 1757 1768 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;0.8 &#177; 0.5<xref ref-type="table-fn" rid="TF8"><sup>#</sup></xref></td>
###xml 1834 1835 1778 1779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF8">*</xref>
###xml 1822 1835 1768 1779 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;2.6 &#177; 0.3<xref ref-type="table-fn" rid="TF8">*</xref></td>
###xml 1847 1848 1789 1790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF8">*</xref>
###xml 1835 1848 1779 1790 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8722;4.4 &#177; 0.6<xref ref-type="table-fn" rid="TF8">*</xref></td>
###xml 1799 1848 1747 1790 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">0&#8211;12 month</td><td rowspan="1" colspan="1">&#8722;0.8 &#177; 0.5<xref ref-type="table-fn" rid="TF8"><sup>#</sup></xref></td><td rowspan="1" colspan="1">&#8722;2.6 &#177; 0.3<xref ref-type="table-fn" rid="TF8">*</xref></td><td rowspan="1" colspan="1">&#8722;4.4 &#177; 0.6<xref ref-type="table-fn" rid="TF8">*</xref></td></tr>
###xml 1167 1848 1163 1790 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">Baseline [mm<sup>3</sup>]</td><td rowspan="1" colspan="1">2133 &#177; 25 (279)</td><td rowspan="1" colspan="1">1846 &#177; 23 (348)</td><td rowspan="1" colspan="1">1631 &#177; 34 (330)</td></tr><tr><td rowspan="1" colspan="1">Rates [mm<sup>3</sup>/year]</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">0&#8211;6 month</td><td rowspan="1" colspan="1">&#8722;19.7 &#177; 17.0 [&#8211;89 to 51] (74)</td><td rowspan="1" colspan="1">&#8211;37.7 &#177; 10.6<xref ref-type="table-fn" rid="TF8">*</xref> [&#8211;144 to 74] (63)</td><td rowspan="1" colspan="1">&#8211;53.5 &#177; 15.6<xref ref-type="table-fn" rid="TF8">*</xref> [&#8211;152 to 62] (59)</td></tr><tr><td rowspan="1" colspan="1">6&#8211;12 month</td><td rowspan="1" colspan="1">&#8722;8.3 &#177; 21.7 [&#8722;105 to 78] (85)</td><td rowspan="1" colspan="1">&#8722;54.2 &#177; 11.8<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;242 to 82] (60)</td><td rowspan="1" colspan="1">&#8722;91.3 &#177; 18.2<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;207 to 63] (62)</td></tr><tr><td rowspan="1" colspan="1">6&#8211;12 month<xref ref-type="table-fn" rid="TF6"><sup>a</sup></xref></td><td rowspan="1" colspan="1">&#8722;6.7 &#177; 18.1 (74)</td><td rowspan="1" colspan="1">&#8722;56.1 &#177; 9.8<xref ref-type="table-fn" rid="TF8">*</xref> (53)</td><td rowspan="1" colspan="1">&#8722;93.0 &#177; 15.0<xref ref-type="table-fn" rid="TF8">*</xref> (50)</td></tr><tr><td rowspan="1" colspan="1">0&#8211;12 month</td><td rowspan="1" colspan="1">&#8722;17.3 &#177; 10.5<xref ref-type="table-fn" rid="TF8"><sup>#</sup></xref> [&#8722;97 to 53] (80)</td><td rowspan="1" colspan="1">&#8722;47.5 &#177; 6.5<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;153 to 79] (65)</td><td rowspan="1" colspan="1">&#8722;72.0 &#177; 9.0<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;162 to 50] (56)</td></tr><tr><td rowspan="1" colspan="1">Percent change/year<xref ref-type="table-fn" rid="TF7"><sup>b</sup></xref></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">0&#8211;6 month</td><td rowspan="1" colspan="1">&#8722;0.9 &#177; 0.8</td><td rowspan="1" colspan="1">&#8722;2.0 &#177; 0.6<xref ref-type="table-fn" rid="TF8">*</xref></td><td rowspan="1" colspan="1">&#8722;3.3 &#177; 0.9<xref ref-type="table-fn" rid="TF8">*</xref></td></tr><tr><td rowspan="1" colspan="1">6&#8211;12 month</td><td rowspan="1" colspan="1">&#8722;0.4 &#177; 1.0</td><td rowspan="1" colspan="1">&#8722;2.9 &#177; 0.6<xref ref-type="table-fn" rid="TF8">*</xref></td><td rowspan="1" colspan="1">&#8722;5.6 &#177; 1.1<xref ref-type="table-fn" rid="TF8">*</xref></td></tr><tr><td rowspan="1" colspan="1">6&#8211;12 month<xref ref-type="table-fn" rid="TF6"><sup>a</sup></xref></td><td rowspan="1" colspan="1">&#8722;0.3 &#177; 0.8</td><td rowspan="1" colspan="1">&#8722;3.0 &#177; 0.5<xref ref-type="table-fn" rid="TF8">*</xref></td><td rowspan="1" colspan="1">&#8722;5.7 &#177; 0.9<xref ref-type="table-fn" rid="TF8">*</xref></td></tr><tr><td rowspan="1" colspan="1">0&#8211;12 month</td><td rowspan="1" colspan="1">&#8722;0.8 &#177; 0.5<xref ref-type="table-fn" rid="TF8"><sup>#</sup></xref></td><td rowspan="1" colspan="1">&#8722;2.6 &#177; 0.3<xref ref-type="table-fn" rid="TF8">*</xref></td><td rowspan="1" colspan="1">&#8722;4.4 &#177; 0.6<xref ref-type="table-fn" rid="TF8">*</xref></td></tr></tbody>
###xml 1117 1848 1113 1790 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Normal</th><th rowspan="1" colspan="1">Mild cognitive impairment</th><th rowspan="1" colspan="1">Alzheimer's disease</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Baseline [mm<sup>3</sup>]</td><td rowspan="1" colspan="1">2133 &#177; 25 (279)</td><td rowspan="1" colspan="1">1846 &#177; 23 (348)</td><td rowspan="1" colspan="1">1631 &#177; 34 (330)</td></tr><tr><td rowspan="1" colspan="1">Rates [mm<sup>3</sup>/year]</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">0&#8211;6 month</td><td rowspan="1" colspan="1">&#8722;19.7 &#177; 17.0 [&#8211;89 to 51] (74)</td><td rowspan="1" colspan="1">&#8211;37.7 &#177; 10.6<xref ref-type="table-fn" rid="TF8">*</xref> [&#8211;144 to 74] (63)</td><td rowspan="1" colspan="1">&#8211;53.5 &#177; 15.6<xref ref-type="table-fn" rid="TF8">*</xref> [&#8211;152 to 62] (59)</td></tr><tr><td rowspan="1" colspan="1">6&#8211;12 month</td><td rowspan="1" colspan="1">&#8722;8.3 &#177; 21.7 [&#8722;105 to 78] (85)</td><td rowspan="1" colspan="1">&#8722;54.2 &#177; 11.8<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;242 to 82] (60)</td><td rowspan="1" colspan="1">&#8722;91.3 &#177; 18.2<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;207 to 63] (62)</td></tr><tr><td rowspan="1" colspan="1">6&#8211;12 month<xref ref-type="table-fn" rid="TF6"><sup>a</sup></xref></td><td rowspan="1" colspan="1">&#8722;6.7 &#177; 18.1 (74)</td><td rowspan="1" colspan="1">&#8722;56.1 &#177; 9.8<xref ref-type="table-fn" rid="TF8">*</xref> (53)</td><td rowspan="1" colspan="1">&#8722;93.0 &#177; 15.0<xref ref-type="table-fn" rid="TF8">*</xref> (50)</td></tr><tr><td rowspan="1" colspan="1">0&#8211;12 month</td><td rowspan="1" colspan="1">&#8722;17.3 &#177; 10.5<xref ref-type="table-fn" rid="TF8"><sup>#</sup></xref> [&#8722;97 to 53] (80)</td><td rowspan="1" colspan="1">&#8722;47.5 &#177; 6.5<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;153 to 79] (65)</td><td rowspan="1" colspan="1">&#8722;72.0 &#177; 9.0<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;162 to 50] (56)</td></tr><tr><td rowspan="1" colspan="1">Percent change/year<xref ref-type="table-fn" rid="TF7"><sup>b</sup></xref></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">0&#8211;6 month</td><td rowspan="1" colspan="1">&#8722;0.9 &#177; 0.8</td><td rowspan="1" colspan="1">&#8722;2.0 &#177; 0.6<xref ref-type="table-fn" rid="TF8">*</xref></td><td rowspan="1" colspan="1">&#8722;3.3 &#177; 0.9<xref ref-type="table-fn" rid="TF8">*</xref></td></tr><tr><td rowspan="1" colspan="1">6&#8211;12 month</td><td rowspan="1" colspan="1">&#8722;0.4 &#177; 1.0</td><td rowspan="1" colspan="1">&#8722;2.9 &#177; 0.6<xref ref-type="table-fn" rid="TF8">*</xref></td><td rowspan="1" colspan="1">&#8722;5.6 &#177; 1.1<xref ref-type="table-fn" rid="TF8">*</xref></td></tr><tr><td rowspan="1" colspan="1">6&#8211;12 month<xref ref-type="table-fn" rid="TF6"><sup>a</sup></xref></td><td rowspan="1" colspan="1">&#8722;0.3 &#177; 0.8</td><td rowspan="1" colspan="1">&#8722;3.0 &#177; 0.5<xref ref-type="table-fn" rid="TF8">*</xref></td><td rowspan="1" colspan="1">&#8722;5.7 &#177; 0.9<xref ref-type="table-fn" rid="TF8">*</xref></td></tr><tr><td rowspan="1" colspan="1">0&#8211;12 month</td><td rowspan="1" colspan="1">&#8722;0.8 &#177; 0.5<xref ref-type="table-fn" rid="TF8"><sup>#</sup></xref></td><td rowspan="1" colspan="1">&#8722;2.6 &#177; 0.3<xref ref-type="table-fn" rid="TF8">*</xref></td><td rowspan="1" colspan="1">&#8722;4.4 &#177; 0.6<xref ref-type="table-fn" rid="TF8">*</xref></td></tr></tbody></table>
###xml 1848 1914 1790 1856 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="37">a Using 0&#8211;6 months as prior and a Markov chain model for analysis.</p>
###xml 1848 1914 1790 1856 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF6"><p textid="37">a Using 0&#8211;6 months as prior and a Markov chain model for analysis.</p></fn>
###xml 1914 1966 1856 1908 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="38">b Percent volume change relative to baseline volume.</p>
###xml 1914 1966 1856 1908 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF7"><p textid="38">b Percent volume change relative to baseline volume.</p></fn>
###xml 1967 1968 1909 1910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1979 1980 1921 1922 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 1980 1981 1922 1923 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1966 1990 1908 1932 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="39">*<italic>P</italic> &lt; 0.0001; <sup>#</sup><italic>P</italic> = 0.005.</p>
###xml 1966 1990 1908 1932 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF8"><p textid="39">*<italic>P</italic> &lt; 0.0001; <sup>#</sup><italic>P</italic> = 0.005.</p></fn>
###xml 1990 2099 1932 2039 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="40">Listed are mean &#177; SE; max/min rates in square brackets; random effect standard deviation in round brackets.</p>
###xml 1990 2099 1932 2039 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="40">Listed are mean &#177; SE; max/min rates in square brackets; random effect standard deviation in round brackets.</p></fn>
###xml 1848 2099 1790 2039 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><fn id="TF6"><p textid="37">a Using 0&#8211;6 months as prior and a Markov chain model for analysis.</p></fn><fn id="TF7"><p textid="38">b Percent volume change relative to baseline volume.</p></fn><fn id="TF8"><p textid="39">*<italic>P</italic> &lt; 0.0001; <sup>#</sup><italic>P</italic> = 0.005.</p></fn><fn><p textid="40">Listed are mean &#177; SE; max/min rates in square brackets; random effect standard deviation in round brackets.</p></fn></table-wrap-foot>
###xml 1015 2099 1011 2039 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T2" position="float"><label>Table 2</label><caption><p textid="36">Hippocampal baseline volumes and rates of volume loss by group for different MRI scan intervals</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Normal</th><th rowspan="1" colspan="1">Mild cognitive impairment</th><th rowspan="1" colspan="1">Alzheimer's disease</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Baseline [mm<sup>3</sup>]</td><td rowspan="1" colspan="1">2133 &#177; 25 (279)</td><td rowspan="1" colspan="1">1846 &#177; 23 (348)</td><td rowspan="1" colspan="1">1631 &#177; 34 (330)</td></tr><tr><td rowspan="1" colspan="1">Rates [mm<sup>3</sup>/year]</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">0&#8211;6 month</td><td rowspan="1" colspan="1">&#8722;19.7 &#177; 17.0 [&#8211;89 to 51] (74)</td><td rowspan="1" colspan="1">&#8211;37.7 &#177; 10.6<xref ref-type="table-fn" rid="TF8">*</xref> [&#8211;144 to 74] (63)</td><td rowspan="1" colspan="1">&#8211;53.5 &#177; 15.6<xref ref-type="table-fn" rid="TF8">*</xref> [&#8211;152 to 62] (59)</td></tr><tr><td rowspan="1" colspan="1">6&#8211;12 month</td><td rowspan="1" colspan="1">&#8722;8.3 &#177; 21.7 [&#8722;105 to 78] (85)</td><td rowspan="1" colspan="1">&#8722;54.2 &#177; 11.8<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;242 to 82] (60)</td><td rowspan="1" colspan="1">&#8722;91.3 &#177; 18.2<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;207 to 63] (62)</td></tr><tr><td rowspan="1" colspan="1">6&#8211;12 month<xref ref-type="table-fn" rid="TF6"><sup>a</sup></xref></td><td rowspan="1" colspan="1">&#8722;6.7 &#177; 18.1 (74)</td><td rowspan="1" colspan="1">&#8722;56.1 &#177; 9.8<xref ref-type="table-fn" rid="TF8">*</xref> (53)</td><td rowspan="1" colspan="1">&#8722;93.0 &#177; 15.0<xref ref-type="table-fn" rid="TF8">*</xref> (50)</td></tr><tr><td rowspan="1" colspan="1">0&#8211;12 month</td><td rowspan="1" colspan="1">&#8722;17.3 &#177; 10.5<xref ref-type="table-fn" rid="TF8"><sup>#</sup></xref> [&#8722;97 to 53] (80)</td><td rowspan="1" colspan="1">&#8722;47.5 &#177; 6.5<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;153 to 79] (65)</td><td rowspan="1" colspan="1">&#8722;72.0 &#177; 9.0<xref ref-type="table-fn" rid="TF8">*</xref> [&#8722;162 to 50] (56)</td></tr><tr><td rowspan="1" colspan="1">Percent change/year<xref ref-type="table-fn" rid="TF7"><sup>b</sup></xref></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">0&#8211;6 month</td><td rowspan="1" colspan="1">&#8722;0.9 &#177; 0.8</td><td rowspan="1" colspan="1">&#8722;2.0 &#177; 0.6<xref ref-type="table-fn" rid="TF8">*</xref></td><td rowspan="1" colspan="1">&#8722;3.3 &#177; 0.9<xref ref-type="table-fn" rid="TF8">*</xref></td></tr><tr><td rowspan="1" colspan="1">6&#8211;12 month</td><td rowspan="1" colspan="1">&#8722;0.4 &#177; 1.0</td><td rowspan="1" colspan="1">&#8722;2.9 &#177; 0.6<xref ref-type="table-fn" rid="TF8">*</xref></td><td rowspan="1" colspan="1">&#8722;5.6 &#177; 1.1<xref ref-type="table-fn" rid="TF8">*</xref></td></tr><tr><td rowspan="1" colspan="1">6&#8211;12 month<xref ref-type="table-fn" rid="TF6"><sup>a</sup></xref></td><td rowspan="1" colspan="1">&#8722;0.3 &#177; 0.8</td><td rowspan="1" colspan="1">&#8722;3.0 &#177; 0.5<xref ref-type="table-fn" rid="TF8">*</xref></td><td rowspan="1" colspan="1">&#8722;5.7 &#177; 0.9<xref ref-type="table-fn" rid="TF8">*</xref></td></tr><tr><td rowspan="1" colspan="1">0&#8211;12 month</td><td rowspan="1" colspan="1">&#8722;0.8 &#177; 0.5<xref ref-type="table-fn" rid="TF8"><sup>#</sup></xref></td><td rowspan="1" colspan="1">&#8722;2.6 &#177; 0.3<xref ref-type="table-fn" rid="TF8">*</xref></td><td rowspan="1" colspan="1">&#8722;4.4 &#177; 0.6<xref ref-type="table-fn" rid="TF8">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="TF6"><p textid="37">a Using 0&#8211;6 months as prior and a Markov chain model for analysis.</p></fn><fn id="TF7"><p textid="38">b Percent volume change relative to baseline volume.</p></fn><fn id="TF8"><p textid="39">*<italic>P</italic> &lt; 0.0001; <sup>#</sup><italic>P</italic> = 0.005.</p></fn><fn><p textid="40">Listed are mean &#177; SE; max/min rates in square brackets; random effect standard deviation in round brackets.</p></fn></table-wrap-foot></table-wrap>
###xml 489 497 <span type="species:ncbi:9606">patients</span>
###xml 767 775 <span type="species:ncbi:9606">patients</span>
Demographics and clinical data of the subjects at baseline are summarized in Table 1. The groups were comparable in age (P = 0.2) and sex distribution (P = 0.2, by chi2), but had markedly different MMSE, ADAS-Cog and CDR scores, as expected (all P < 0.001). While mild cognitive impairment and Alzheimer's disease subjects had similar GDS scores (P = 0.5), their scores were both markedly higher than those of normal subjects (P < 0.001). Mild cognitive impairment and Alzheimer's disease patients also had more than 2-fold higher rates of ApoE4 carriers than the normal subjects (P < 0.001, by chi2). Estimations of hippocampal volumes (in cubic millimetre, left and right averaged) at baseline are listed in Table 2 for each group. As expected, Alzheimer's disease patients had smaller hippocampal volumes than mild cognitive impairment subjects (P < 0.0001) and both had smaller volumes than normal subjects (P < 0.0001). Smaller baseline volumes were significantly associated with age (P < 0.01) in each group. Table 2Hippocampal baseline volumes and rates of volume loss by group for different MRI scan intervalsNormalMild cognitive impairmentAlzheimer's diseaseBaseline [mm3]2133 +/- 25 (279)1846 +/- 23 (348)1631 +/- 34 (330)Rates [mm3/year]0-6 month-19.7 +/- 17.0 [-89 to 51] (74)-37.7 +/- 10.6* [-144 to 74] (63)-53.5 +/- 15.6* [-152 to 62] (59)6-12 month-8.3 +/- 21.7 [-105 to 78] (85)-54.2 +/- 11.8* [-242 to 82] (60)-91.3 +/- 18.2* [-207 to 63] (62)6-12 montha-6.7 +/- 18.1 (74)-56.1 +/- 9.8* (53)-93.0 +/- 15.0* (50)0-12 month-17.3 +/- 10.5# [-97 to 53] (80)-47.5 +/- 6.5* [-153 to 79] (65)-72.0 +/- 9.0* [-162 to 50] (56)Percent change/yearb0-6 month-0.9 +/- 0.8-2.0 +/- 0.6*-3.3 +/- 0.9*6-12 month-0.4 +/- 1.0-2.9 +/- 0.6*-5.6 +/- 1.1*6-12 montha-0.3 +/- 0.8-3.0 +/- 0.5*-5.7 +/- 0.9*0-12 month-0.8 +/- 0.5#-2.6 +/- 0.3*-4.4 +/- 0.6*a Using 0-6 months as prior and a Markov chain model for analysis.b Percent volume change relative to baseline volume.*P < 0.0001; #P = 0.005.Listed are mean +/- SE; max/min rates in square brackets; random effect standard deviation in round brackets.
###end p 35
###begin p 36
Hippocampal baseline volumes and rates of volume loss by group for different MRI scan intervals
###end p 36
###begin p 37
a Using 0-6 months as prior and a Markov chain model for analysis.
###end p 37
###begin p 38
b Percent volume change relative to baseline volume.
###end p 38
###begin p 39
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 13 14 13 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 14 15 14 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
*P < 0.0001; #P = 0.005.
###end p 39
###begin p 40
Listed are mean +/- SE; max/min rates in square brackets; random effect standard deviation in round brackets.
###end p 40
###begin title 41
Rates of hippocampal volume loss
###end title 41
###begin p 42
###xml 82 83 82 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 223 229 223 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 617 624 617 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 1075 1076 1075 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1163 1164 1163 1164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1846 1847 1846 1847 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1975 1976 1971 1972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1985 1993 1981 1989 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1</label>
###xml 1993 2162 1989 2158 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="43">Individual trajectories of hippocampal volume change from one-third of the subjects, randomly selected. The thick black lines indicate the mean trajectory of each group.</p>
###xml 1993 2162 1989 2158 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="43">Individual trajectories of hippocampal volume change from one-third of the subjects, randomly selected. The thick black lines indicate the mean trajectory of each group.</p></caption>
###xml 2162 2162 2158 2158 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="awp007f1"/>
###xml 1985 2162 1981 2158 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F1" position="float"><label>Figure 1</label><caption><p textid="43">Individual trajectories of hippocampal volume change from one-third of the subjects, randomly selected. The thick black lines indicate the mean trajectory of each group.</p></caption><graphic xlink:href="awp007f1"/></fig>
###xml 408 416 <span type="species:ncbi:9606">patients</span>
###xml 544 552 <span type="species:ncbi:9606">patients</span>
###xml 1443 1451 <span type="species:ncbi:9606">patients</span>
###xml 1563 1571 <span type="species:ncbi:9606">patients</span>
Differences in rates between the left and right hippocampus were not significant (P > 0.2) and therefore the values were averaged. Individual trajectories of hippocampal volume changes as a function of time are depicted in Fig. 1 for one-third of the subjects, randomly selected. The thick solid line in each panel represents the mean change in each respective group. This indicates that Alzheimer's disease patients had on average a smaller hippocampus and greater volume loss over time than normal subjects, whereas mild cognitive impairment patients had intermediate values between Alzheimer's disease and normal. Table 2 lists the estimated rates of hippocampal volume loss (in cublic millimetre/year) for each group, separately for 0-6 m, 6-12 m and 0-12 m scan intervals. The rates of volume loss are also given in annualized percentage change relative to baseline for comparison with other publications. The rates are adjusted for subject age at baseline. At 0-6 m, hippocampal loss in mild cognitive impairment and Alzheimer's disease was already highly significant (P < 0.0001), whereas the loss in normal became significant in the 0-12 m interval only (P = 0.005). In general, the estimations of hippocampal loss were more robust from measurements over the 0-12 m interval than over 0-6 m and 6-12 m, as indicated by smaller standard errors and correspondingly higher significance levels. For all scan intervals, Alzheimer's disease patients had a markedly higher average rate of hippocampal loss than normal subjects, whereas mild cognitive impairment patients had an intermediate rate between Alzheimer's disease and normal. There was no significant age by atrophy rates interaction for any group. Given the number of subjects in this study, e.g. mild cognitive impairment, the minimum detectable difference in atrophy rates was 25 mm3/year at 80% power (alpha = 0.05). Neither baseline volume nor rates were significantly associated with severity of depression (P = 0.8). Figure 1Individual trajectories of hippocampal volume change from one-third of the subjects, randomly selected. The thick black lines indicate the mean trajectory of each group.
###end p 42
###begin p 43
Individual trajectories of hippocampal volume change from one-third of the subjects, randomly selected. The thick black lines indicate the mean trajectory of each group.
###end p 43
###begin p 44
###xml 216 223 216 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 632 633 632 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
For comparison, rates derived from an analysis using the Markov chain approach, in which the observations from scan interval 0-6 m were explicitly used to estimate the rates in the 6-12 m interval are also listed in Table 2. Compared to the regular analysis of 6-12 m data, the Markov chain approach yielded markedly smaller random variations in addition to smaller standard errors in rates. The inclusion of the 0-6 m data made a significant contribution to the estimation of rates from the 6-12 m data for all groups [normal: likelihood ratio (LR) = 32.7; mild cognitive impairment: LR = 46.7; Alzheimer's disease: LR = 36.3; all P < 0.0001].
###end p 44
###begin p 45
###xml 98 104 98 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Fig. 2</xref>
###xml 302 303 302 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 342 343 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 470 471 468 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 476 477 474 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 520 521 516 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 526 527 522 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 590 591 584 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 613 614 605 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 659 667 651 659 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2</label>
###xml 667 717 659 709 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="46">Accelerations of rates of hippocampal volume loss.</p>
###xml 667 717 659 709 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="46">Accelerations of rates of hippocampal volume loss.</p></caption>
###xml 717 717 709 709 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="awp007f2"/>
###xml 659 717 651 709 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F2" position="float"><label>Figure 2</label><caption><p textid="46">Accelerations of rates of hippocampal volume loss.</p></caption><graphic xlink:href="awp007f2"/></fig>
###xml 249 257 <span type="species:ncbi:9606">patients</span>
We further tested whether the rates of hippocampal loss accelerated. The box-and-whisker plots in Fig. 2 depict the change of hippocampal loss between 0-6 and 6-12 m scan intervals by group. In both mild cognitive impairment and Alzheimer's disease patients, the rates of hippocampal loss accelerated (P = 0.0001) but not in normal subjects (P = 0.2). Based on a quadratic expansion of time in the constant rate model, the hippocampal loss accelerated by 26.5 +/- 4.5 mm3/year2 in Alzheimer's disease and 12.1 +/- 3.2 mm3/year2 in mild cognitive impairment, equivalent to -1.6 +/- 0.2%/year2 and 0.6 +/- 0.2%/year2, respectively, relative to baseline volume. Figure 2Accelerations of rates of hippocampal volume loss.
###end p 45
###begin p 46
Accelerations of rates of hippocampal volume loss.
###end p 46
###begin title 47
Correlations between rates of volume loss and cognitive decline
###end title 47
###begin p 48
###xml 149 150 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 160 161 160 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 356 357 356 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 366 367 366 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 139 147 <span type="species:ncbi:9606">patients</span>
###xml 346 354 <span type="species:ncbi:9606">patients</span>
The rates of ADAS-Cog (log transformed) correlated with the rates of hippocampal loss in Alzheimer's disease and mild cognitive impairment patients (r = -0.27; P = 0.0005 by Spearman rank). Similarly, the rates of change in MMSE (log transformed) correlated with the rates of hippocampal loss in Alzheimer's disease and mild cognitive impairment patients (r = 0.18, P = 0.04 by Spearman rank).
###end p 48
###begin title 49
ApoE profile and modulations of rates of hippocampal loss
###end title 49
###begin p 50
###xml 63 69 63 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Fig. 3</xref>
###xml 172 173 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 223 224 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 355 356 353 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 483 484 479 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1084 1085 1026 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 1227 1228 1169 1170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1237 1245 1179 1187 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3</label>
###xml 1245 1316 1187 1258 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="51">Rates of hippocampal volume loss in carriers and non-carriers of ApoE4.</p>
###xml 1245 1316 1187 1258 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="51">Rates of hippocampal volume loss in carriers and non-carriers of ApoE4.</p></caption>
###xml 1316 1316 1258 1258 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="awp007f3"/>
###xml 1237 1316 1179 1258 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F3" position="float"><label>Figure 3</label><caption><p textid="51">Rates of hippocampal volume loss in carriers and non-carriers of ApoE4.</p></caption><graphic xlink:href="awp007f3"/></fig>
###xml 299 307 <span type="species:ncbi:9606">patients</span>
###xml 444 452 <span type="species:ncbi:9606">patients</span>
The effect of ApoE on rates of hippocampal loss is depicted in Fig. 3. Presence of the ApoE4 gene was generally associated with higher rates of hippocampal loss (LR = 4.4; P = 0.03) and smaller baseline volumes (LR = 27.2; P < 0.0001). The ApoE4 effect on rates was dominated by Alzheimer's disease patients with ApoE4, who lost on average 23.4 +/- 8.4 mm3/year (1.4 +/- 0.5%/year loss relative to baseline volume) more hippocampal volume than patients not carrying ApoE4 (LR = 7.8; P = 0.005), irrespective of the severity of cognitive impairments (based on ADAS-Cog). A direct comparison between epsilon3/3 with epsilon3/4 carriers (i.e. excluding those with alleles epsilon2/2, epsilon2/3, epsilon2/4 and epsilon4/4) yielded virtually, the same result. We also explored the dose effect of ApoE4 on hippocampal loss rates by comparing epsilon3/4 and epsilon4/4 carriers (epsilon2/4 carriers were not considered because there were only three) but found no significant effect. Interrelationships between explanatory variables (ApoE, age, ADAS-Cog) for rates of volume loss were weak (r < 0.2 for all). In normal and mild cognitive impairment subjects, ApoE4 was not significantly associated with higher hippocampal loss rates (P = 0.9). Figure 3Rates of hippocampal volume loss in carriers and non-carriers of ApoE4.
###end p 50
###begin p 51
Rates of hippocampal volume loss in carriers and non-carriers of ApoE4.
###end p 51
###begin title 52
Rates of hippocampal loss and CSF biomarkers concentrations
###end title 52
###begin p 53
###xml 109 113 106 110 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 343 347 337 341 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 629 633 602 606 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 649 650 622 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 825 829 795 799 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 900 901 870 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r</italic>
###xml 921 925 888 892 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 1038 1042 1002 1006 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 1149 1150 1111 1112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1202 1206 1161 1165 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 1215 1216 1174 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
We also tested if the rates of hippocampal loss are correlated with the concentration of CSF biomarkers Abeta1-42, t-tau and p-tau at baseline on a smaller sample (68 normal, 109 mild cognitive impairment, 53 Alzheimer's disease), whose biomarker data were available at the time of the analysis. The baseline concentrations (in pg/ml) of Abeta1-42, t-tau and p-tau, respectively, were: 137 +/- 39/119 +/- 59/40 +/- 17 in Alzheimer's disease; 159 +/- 54/104 +/- 52/36 +/- 17 in mild cognitive impairment; and 211 +/- 54/70 +/- 30/25 +/- 14 in control. Overall, higher rates of hippocampal loss were associated with decreased Abeta1-42 concentration (P < 0.01). The effect remained significant after accounting for ApoE genotype and level of cognitive impairment. Among the explanatory variables for rates of volume loss, Abeta1-42 and ApoE were the only ones that had a significant interrelationship (r = -0.58) with Abeta1-42 contributing 1.5 times as much to the variability of hippocampus atrophy rates than ApoE. The link between Abeta1-42 and hippocampal rates was driven by mild cognitive impairment subjects, who lost on average 0.3 +/- 0.1 mm3/year hippocampal volume per pg/ml decrease of Abeta1-42 in CSF (P = 0.04), equivalent to 0.02 +/- 0.01%/year loss relative to baseline volume.
###end p 53
###begin p 54
###xml 40 44 37 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 90 91 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 116 117 113 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 150 156 147 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Fig. 4</xref>
###xml 224 228 218 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 276 280 267 271 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 410 414 398 402 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 443 447 428 432 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 543 544 528 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 721 729 706 714 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4</label>
###xml 799 803 781 785 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 729 825 714 807 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="55">Associations between annual rates of hippocampal volume loss and A&#946;<sub>1&#8211;42</sub> concentration in CSF.</p>
###xml 729 825 714 807 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="55">Associations between annual rates of hippocampal volume loss and A&#946;<sub>1&#8211;42</sub> concentration in CSF.</p></caption>
###xml 825 825 807 807 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="awp007f4"/>
###xml 721 825 706 807 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F4" position="float"><label>Figure 4</label><caption><p textid="55">Associations between annual rates of hippocampal volume loss and A&#946;<sub>1&#8211;42</sub> concentration in CSF.</p></caption><graphic xlink:href="awp007f4"/></fig>
###xml 598 606 <span type="species:ncbi:9606">patients</span>
No significant correlation between Abeta1-42 and MRI was seen in the Alzheimer's disease (P = 0.1) or normal group (P = 0.5). The regression plots in Fig. 4 depict the relationship between rates of hippocampal loss and Abeta1-42 concentration, separately by group. Note, Abeta1-42 concentration is plotted on a logarithmic scale to stabilize the regressions by imposing a more uniform distribution of the Abeta1-42 values. In contrast to Abeta1-42, the correlation between CSF t-tau concentrations and hippocampal loss rates was only a trend (P = 0.058) and this was limited to Alzheimer's disease patients. There were no significant correlations between CSF p-tau concentrations and hippocampal loss rates in any group. Figure 4Associations between annual rates of hippocampal volume loss and Abeta1-42 concentration in CSF.
###end p 54
###begin p 55
###xml 70 74 67 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
Associations between annual rates of hippocampal volume loss and Abeta1-42 concentration in CSF.
###end p 55
###begin title 56
Sample size
###end title 56
###begin p 57
###xml 732 736 725 729 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 867 874 860 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 1615 1619 1605 1609 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 2248 2255 2238 2245 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table 3</label>
###xml 2255 2373 2245 2359 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="58">Estimations of sample size per arm for a hypothetical trial to detect 25% rate slowing with 90% power and &#945; = 0.05</p>
###xml 2255 2373 2245 2359 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="58">Estimations of sample size per arm for a hypothetical trial to detect 25% rate slowing with 90% power and &#945; = 0.05</p></caption>
###xml 2373 2385 2359 2371 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Study design</th>
###xml 2385 2404 2371 2390 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Alzheimer's disease</th>
###xml 2404 2429 2390 2415 <th xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">Mild cognitive impairment</th>
###xml 2373 2429 2359 2415 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><th rowspan="1" colspan="1">Study design</th><th rowspan="1" colspan="1">Alzheimer's disease</th><th rowspan="1" colspan="1">Mild cognitive impairment</th></tr>
###xml 2373 2429 2359 2415 <thead xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><th rowspan="1" colspan="1">Study design</th><th rowspan="1" colspan="1">Alzheimer's disease</th><th rowspan="1" colspan="1">Mild cognitive impairment</th></tr></thead>
###xml 2429 2451 2415 2437 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MRI Hippocampal volume</td>
###xml 2451 2451 2437 2437 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2451 2451 2437 2437 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2429 2451 2415 2437 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">MRI Hippocampal volume</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 2471 2472 2457 2458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 2471 2472 2457 2458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF9"><sup>a</sup></xref>
###xml 2451 2472 2437 2458 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two scans, 0&#8211;6 m<xref ref-type="table-fn" rid="TF9"><sup>a</sup></xref></td>
###xml 2472 2475 2458 2461 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">462</td>
###xml 2475 2478 2461 2464 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">949</td>
###xml 2451 2478 2437 2464 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two scans, 0&#8211;6 m<xref ref-type="table-fn" rid="TF9"><sup>a</sup></xref></td><td rowspan="1" colspan="1">462</td><td rowspan="1" colspan="1">949</td></tr>
###xml 2499 2500 2485 2486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 2499 2500 2485 2486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF9"><sup>a</sup></xref>
###xml 2478 2500 2464 2486 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two scans, 0&#8211;12 m<xref ref-type="table-fn" rid="TF9"><sup>a</sup></xref></td>
###xml 2500 2503 2486 2489 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">252</td>
###xml 2503 2506 2489 2492 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">698</td>
###xml 2478 2506 2464 2492 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two scans, 0&#8211;12 m<xref ref-type="table-fn" rid="TF9"><sup>a</sup></xref></td><td rowspan="1" colspan="1">252</td><td rowspan="1" colspan="1">698</td></tr>
###xml 2531 2532 2517 2518 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 2531 2532 2517 2518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF9"><sup>a</sup></xref>
###xml 2506 2532 2492 2518 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans, 0&#8211;6&#8211;12 m<xref ref-type="table-fn" rid="TF9"><sup>a</sup></xref></td>
###xml 2532 2535 2518 2521 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">255</td>
###xml 2535 2538 2521 2524 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">673</td>
###xml 2506 2538 2492 2524 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans, 0&#8211;6&#8211;12 m<xref ref-type="table-fn" rid="TF9"><sup>a</sup></xref></td><td rowspan="1" colspan="1">255</td><td rowspan="1" colspan="1">673</td></tr>
###xml 2561 2562 2547 2548 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</sup>
###xml 2561 2562 2547 2548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF10"><sup>b</sup></xref>
###xml 2538 2562 2524 2548 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans + ApoE4<xref ref-type="table-fn" rid="TF10"><sup>b</sup></xref></td>
###xml 2562 2565 2548 2551 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">196</td>
###xml 2565 2568 2551 2554 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">672</td>
###xml 2538 2568 2524 2554 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans + ApoE4<xref ref-type="table-fn" rid="TF10"><sup>b</sup></xref></td><td rowspan="1" colspan="1">196</td><td rowspan="1" colspan="1">672</td></tr>
###xml 2588 2589 2574 2575 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</sup>
###xml 2588 2589 2574 2575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF11"><sup>c</sup></xref>
###xml 2568 2589 2554 2575 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans + MC<xref ref-type="table-fn" rid="TF11"><sup>c</sup></xref></td>
###xml 2589 2592 2575 2578 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">140</td>
###xml 2592 2595 2578 2581 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">383</td>
###xml 2568 2595 2554 2581 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans + MC<xref ref-type="table-fn" rid="TF11"><sup>c</sup></xref></td><td rowspan="1" colspan="1">140</td><td rowspan="1" colspan="1">383</td></tr>
###xml 2623 2624 2609 2610 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sup>
###xml 2623 2624 2609 2610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF12"><sup>d</sup></xref>
###xml 2595 2624 2581 2610 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans + MC + ApoE4<xref ref-type="table-fn" rid="TF12"><sup>d</sup></xref></td>
###xml 2624 2626 2610 2612 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">86</td>
###xml 2626 2629 2612 2615 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">341</td>
###xml 2595 2629 2581 2615 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans + MC + ApoE4<xref ref-type="table-fn" rid="TF12"><sup>d</sup></xref></td><td rowspan="1" colspan="1">86</td><td rowspan="1" colspan="1">341</td></tr>
###xml 2637 2638 2623 2624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</sup>
###xml 2637 2638 2623 2624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF13"><sup>e</sup></xref>
###xml 2629 2638 2615 2624 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">ADAS-Cog<xref ref-type="table-fn" rid="TF13"><sup>e</sup></xref></td>
###xml 2638 2638 2624 2624 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2638 2638 2624 2624 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2629 2638 2615 2624 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">ADAS-Cog<xref ref-type="table-fn" rid="TF13"><sup>e</sup></xref></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 2638 2658 2624 2644 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;6 m</td>
###xml 2658 2661 2644 2647 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">745</td>
###xml 2661 2665 2647 2651 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">4663</td>
###xml 2638 2665 2624 2651 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;6 m</td><td rowspan="1" colspan="1">745</td><td rowspan="1" colspan="1">4663</td></tr>
###xml 2665 2686 2651 2672 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;12 m</td>
###xml 2686 2689 2672 2675 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">814</td>
###xml 2689 2693 2675 2679 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">9350</td>
###xml 2665 2693 2651 2679 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;12 m</td><td rowspan="1" colspan="1">814</td><td rowspan="1" colspan="1">9350</td></tr>
###xml 2693 2718 2679 2704 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three tests, 0&#8211;6&#8211;12 m</td>
###xml 2718 2721 2704 2707 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">569</td>
###xml 2721 2725 2707 2711 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">8354</td>
###xml 2693 2725 2679 2711 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three tests, 0&#8211;6&#8211;12 m</td><td rowspan="1" colspan="1">569</td><td rowspan="1" colspan="1">8354</td></tr>
###xml 2729 2730 2715 2716 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e</sup>
###xml 2729 2730 2715 2716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="TF13"><sup>e</sup></xref>
###xml 2725 2730 2711 2716 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">MMSE<xref ref-type="table-fn" rid="TF13"><sup>e</sup></xref></td>
###xml 2730 2730 2716 2716 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2730 2730 2716 2716 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1"/>
###xml 2725 2730 2711 2716 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">MMSE<xref ref-type="table-fn" rid="TF13"><sup>e</sup></xref></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr>
###xml 2730 2750 2716 2736 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;6 m</td>
###xml 2750 2754 2736 2740 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1280</td>
###xml 2754 2758 2740 2744 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">6300</td>
###xml 2730 2758 2716 2744 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;6 m</td><td rowspan="1" colspan="1">1280</td><td rowspan="1" colspan="1">6300</td></tr>
###xml 2758 2779 2744 2765 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;12 m</td>
###xml 2779 2783 2765 2769 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">1083</td>
###xml 2783 2787 2769 2773 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">3900</td>
###xml 2758 2787 2744 2773 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;12 m</td><td rowspan="1" colspan="1">1083</td><td rowspan="1" colspan="1">3900</td></tr>
###xml 2787 2812 2773 2798 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three tests, 0&#8211;6&#8211;12 m</td>
###xml 2812 2815 2798 2801 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">780</td>
###xml 2815 2819 2801 2805 <td xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rowspan="1" colspan="1">3353</td>
###xml 2787 2819 2773 2805 <tr xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three tests, 0&#8211;6&#8211;12 m</td><td rowspan="1" colspan="1">780</td><td rowspan="1" colspan="1">3353</td></tr>
###xml 2429 2819 2415 2805 <tbody xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" align="left"><tr><td rowspan="1" colspan="1">MRI Hippocampal volume</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two scans, 0&#8211;6 m<xref ref-type="table-fn" rid="TF9"><sup>a</sup></xref></td><td rowspan="1" colspan="1">462</td><td rowspan="1" colspan="1">949</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two scans, 0&#8211;12 m<xref ref-type="table-fn" rid="TF9"><sup>a</sup></xref></td><td rowspan="1" colspan="1">252</td><td rowspan="1" colspan="1">698</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans, 0&#8211;6&#8211;12 m<xref ref-type="table-fn" rid="TF9"><sup>a</sup></xref></td><td rowspan="1" colspan="1">255</td><td rowspan="1" colspan="1">673</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans + ApoE4<xref ref-type="table-fn" rid="TF10"><sup>b</sup></xref></td><td rowspan="1" colspan="1">196</td><td rowspan="1" colspan="1">672</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans + MC<xref ref-type="table-fn" rid="TF11"><sup>c</sup></xref></td><td rowspan="1" colspan="1">140</td><td rowspan="1" colspan="1">383</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans + MC + ApoE4<xref ref-type="table-fn" rid="TF12"><sup>d</sup></xref></td><td rowspan="1" colspan="1">86</td><td rowspan="1" colspan="1">341</td></tr><tr><td rowspan="1" colspan="1">ADAS-Cog<xref ref-type="table-fn" rid="TF13"><sup>e</sup></xref></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;6 m</td><td rowspan="1" colspan="1">745</td><td rowspan="1" colspan="1">4663</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;12 m</td><td rowspan="1" colspan="1">814</td><td rowspan="1" colspan="1">9350</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three tests, 0&#8211;6&#8211;12 m</td><td rowspan="1" colspan="1">569</td><td rowspan="1" colspan="1">8354</td></tr><tr><td rowspan="1" colspan="1">MMSE<xref ref-type="table-fn" rid="TF13"><sup>e</sup></xref></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;6 m</td><td rowspan="1" colspan="1">1280</td><td rowspan="1" colspan="1">6300</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;12 m</td><td rowspan="1" colspan="1">1083</td><td rowspan="1" colspan="1">3900</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three tests, 0&#8211;6&#8211;12 m</td><td rowspan="1" colspan="1">780</td><td rowspan="1" colspan="1">3353</td></tr></tbody>
###xml 2373 2819 2359 2805 <table xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Study design</th><th rowspan="1" colspan="1">Alzheimer's disease</th><th rowspan="1" colspan="1">Mild cognitive impairment</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">MRI Hippocampal volume</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two scans, 0&#8211;6 m<xref ref-type="table-fn" rid="TF9"><sup>a</sup></xref></td><td rowspan="1" colspan="1">462</td><td rowspan="1" colspan="1">949</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two scans, 0&#8211;12 m<xref ref-type="table-fn" rid="TF9"><sup>a</sup></xref></td><td rowspan="1" colspan="1">252</td><td rowspan="1" colspan="1">698</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans, 0&#8211;6&#8211;12 m<xref ref-type="table-fn" rid="TF9"><sup>a</sup></xref></td><td rowspan="1" colspan="1">255</td><td rowspan="1" colspan="1">673</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans + ApoE4<xref ref-type="table-fn" rid="TF10"><sup>b</sup></xref></td><td rowspan="1" colspan="1">196</td><td rowspan="1" colspan="1">672</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans + MC<xref ref-type="table-fn" rid="TF11"><sup>c</sup></xref></td><td rowspan="1" colspan="1">140</td><td rowspan="1" colspan="1">383</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans + MC + ApoE4<xref ref-type="table-fn" rid="TF12"><sup>d</sup></xref></td><td rowspan="1" colspan="1">86</td><td rowspan="1" colspan="1">341</td></tr><tr><td rowspan="1" colspan="1">ADAS-Cog<xref ref-type="table-fn" rid="TF13"><sup>e</sup></xref></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;6 m</td><td rowspan="1" colspan="1">745</td><td rowspan="1" colspan="1">4663</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;12 m</td><td rowspan="1" colspan="1">814</td><td rowspan="1" colspan="1">9350</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three tests, 0&#8211;6&#8211;12 m</td><td rowspan="1" colspan="1">569</td><td rowspan="1" colspan="1">8354</td></tr><tr><td rowspan="1" colspan="1">MMSE<xref ref-type="table-fn" rid="TF13"><sup>e</sup></xref></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;6 m</td><td rowspan="1" colspan="1">1280</td><td rowspan="1" colspan="1">6300</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;12 m</td><td rowspan="1" colspan="1">1083</td><td rowspan="1" colspan="1">3900</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three tests, 0&#8211;6&#8211;12 m</td><td rowspan="1" colspan="1">780</td><td rowspan="1" colspan="1">3353</td></tr></tbody></table>
###xml 2819 2891 2805 2877 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="59">a Based on MRI scans at baseline (0 m), 6 (6 m) and/or 12 months (12 m).</p>
###xml 2819 2891 2805 2877 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF9"><p textid="59">a Based on MRI scans at baseline (0 m), 6 (6 m) and/or 12 months (12 m).</p></fn>
###xml 2891 2922 2877 2908 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="60">b Accounting for ApoE4 profile.</p>
###xml 2891 2922 2877 2908 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF10"><p textid="60">b Accounting for ApoE4 profile.</p></fn>
###xml 2922 2979 2908 2965 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="61">c Using the Markov chain approach (see text for details).</p>
###xml 2922 2979 2908 2965 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF11"><p textid="61">c Using the Markov chain approach (see text for details).</p></fn>
###xml 2979 3019 2965 3005 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="62">d Using ApoE4 and Markov chain together.</p>
###xml 2979 3019 2965 3005 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF12"><p textid="62">d Using ApoE4 and Markov chain together.</p></fn>
###xml 3019 3095 3005 3081 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="63">e Using the Markov chain approach did not significantly improve sample size.</p>
###xml 3019 3095 3005 3081 <fn xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="TF13"><p textid="63">e Using the Markov chain approach did not significantly improve sample size.</p></fn>
###xml 2819 3095 2805 3081 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><fn id="TF9"><p textid="59">a Based on MRI scans at baseline (0 m), 6 (6 m) and/or 12 months (12 m).</p></fn><fn id="TF10"><p textid="60">b Accounting for ApoE4 profile.</p></fn><fn id="TF11"><p textid="61">c Using the Markov chain approach (see text for details).</p></fn><fn id="TF12"><p textid="62">d Using ApoE4 and Markov chain together.</p></fn><fn id="TF13"><p textid="63">e Using the Markov chain approach did not significantly improve sample size.</p></fn></table-wrap-foot>
###xml 2248 3095 2238 3081 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="T3" position="float"><label>Table 3</label><caption><p textid="58">Estimations of sample size per arm for a hypothetical trial to detect 25% rate slowing with 90% power and &#945; = 0.05</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Study design</th><th rowspan="1" colspan="1">Alzheimer's disease</th><th rowspan="1" colspan="1">Mild cognitive impairment</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">MRI Hippocampal volume</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two scans, 0&#8211;6 m<xref ref-type="table-fn" rid="TF9"><sup>a</sup></xref></td><td rowspan="1" colspan="1">462</td><td rowspan="1" colspan="1">949</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two scans, 0&#8211;12 m<xref ref-type="table-fn" rid="TF9"><sup>a</sup></xref></td><td rowspan="1" colspan="1">252</td><td rowspan="1" colspan="1">698</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans, 0&#8211;6&#8211;12 m<xref ref-type="table-fn" rid="TF9"><sup>a</sup></xref></td><td rowspan="1" colspan="1">255</td><td rowspan="1" colspan="1">673</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans + ApoE4<xref ref-type="table-fn" rid="TF10"><sup>b</sup></xref></td><td rowspan="1" colspan="1">196</td><td rowspan="1" colspan="1">672</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans + MC<xref ref-type="table-fn" rid="TF11"><sup>c</sup></xref></td><td rowspan="1" colspan="1">140</td><td rowspan="1" colspan="1">383</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three scans + MC + ApoE4<xref ref-type="table-fn" rid="TF12"><sup>d</sup></xref></td><td rowspan="1" colspan="1">86</td><td rowspan="1" colspan="1">341</td></tr><tr><td rowspan="1" colspan="1">ADAS-Cog<xref ref-type="table-fn" rid="TF13"><sup>e</sup></xref></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;6 m</td><td rowspan="1" colspan="1">745</td><td rowspan="1" colspan="1">4663</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;12 m</td><td rowspan="1" colspan="1">814</td><td rowspan="1" colspan="1">9350</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three tests, 0&#8211;6&#8211;12 m</td><td rowspan="1" colspan="1">569</td><td rowspan="1" colspan="1">8354</td></tr><tr><td rowspan="1" colspan="1">MMSE<xref ref-type="table-fn" rid="TF13"><sup>e</sup></xref></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;6 m</td><td rowspan="1" colspan="1">1280</td><td rowspan="1" colspan="1">6300</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Two tests, 0&#8211;12 m</td><td rowspan="1" colspan="1">1083</td><td rowspan="1" colspan="1">3900</td></tr><tr><td rowspan="1" colspan="1">&#8195;&#8195;&#8195;&#8195;Three tests, 0&#8211;6&#8211;12 m</td><td rowspan="1" colspan="1">780</td><td rowspan="1" colspan="1">3353</td></tr></tbody></table><table-wrap-foot><fn id="TF9"><p textid="59">a Based on MRI scans at baseline (0 m), 6 (6 m) and/or 12 months (12 m).</p></fn><fn id="TF10"><p textid="60">b Accounting for ApoE4 profile.</p></fn><fn id="TF11"><p textid="61">c Using the Markov chain approach (see text for details).</p></fn><fn id="TF12"><p textid="62">d Using ApoE4 and Markov chain together.</p></fn><fn id="TF13"><p textid="63">e Using the Markov chain approach did not significantly improve sample size.</p></fn></table-wrap-foot></table-wrap>
###xml 1528 1536 <span type="species:ncbi:9606">patients</span>
###xml 1578 1586 <span type="species:ncbi:9606">patients</span>
To determine the power of MRI in detecting effects on hippocampal volume loss over time we estimated the sample size needed in a hypothetical treatment trial to measure a 25% slowing in the rate of volume loss with 90% confidence and alpha = 0.05 significance. We considered two separate strategies to maximize power: in the first strategy, we considered increasing either the inter-scan interval from 0-6 to 0-12 m or alternatively increasing the number of MRI scans from two to three, i.e. scanning at 0-6-12 m. In the second strategy, we considered gaining power by using prior information, such as exploiting correlations between successive observations by Markov chain analysis and/or by considering the ApoE4 profile and Abeta1-42 concentration in CSF at baseline. The powers, expressed as sample sizes estimations of the different strategies are summarized in Table 3, separately for Alzheimer's disease and mild cognitive impairment. This shows in general that prolonging the inter-scan interval from 6 to 12 months reduced the sample size, as expected. The use of three time-points instead of two lowered the sample size for mild cognitive impairment and accounting for ApoE4 lowered the sample size for Alzheimer's disease. By far the most effective reduction of sample size in this context was accomplished by exploiting correlations between observations, i.e. using Markov chain analysis. Accounting for ApoE4 status in the Markov chain analysis further reduced the sample size for Alzheimer's disease to finally 86 patients and for mild cognitive impairment to 341 patients per arm. Including the Abeta1-42 concentration in CSF at baseline did not lead to additional improvements. We also considered the rate of dropouts in power estimations of three versus two scans. For a Markov chain analysis, which requires at least three scans, the dropout rate has to exceed roughly 20% before the power benefit compared to a conventional mixed effects analysis with only two scans is lost. In contrast to Markov chain, a conventional mixed effects analysis with three scans holds a slight advantage over one with two scans as long as the dropout is less than about 5%. In this study, the dropout rate between two and three scans was about 5%. Table 3Estimations of sample size per arm for a hypothetical trial to detect 25% rate slowing with 90% power and alpha = 0.05Study designAlzheimer's diseaseMild cognitive impairmentMRI Hippocampal volume    Two scans, 0-6 ma462949    Two scans, 0-12 ma252698    Three scans, 0-6-12 ma255673    Three scans + ApoE4b196672    Three scans + MCc140383    Three scans + MC + ApoE4d86341ADAS-Coge    Two tests, 0-6 m7454663    Two tests, 0-12 m8149350    Three tests, 0-6-12 m5698354MMSEe    Two tests, 0-6 m12806300    Two tests, 0-12 m10833900    Three tests, 0-6-12 m7803353a Based on MRI scans at baseline (0 m), 6 (6 m) and/or 12 months (12 m).b Accounting for ApoE4 profile.c Using the Markov chain approach (see text for details).d Using ApoE4 and Markov chain together.e Using the Markov chain approach did not significantly improve sample size.
###end p 57
###begin p 58
Estimations of sample size per arm for a hypothetical trial to detect 25% rate slowing with 90% power and alpha = 0.05
###end p 58
###begin p 59
a Based on MRI scans at baseline (0 m), 6 (6 m) and/or 12 months (12 m).
###end p 59
###begin p 60
b Accounting for ApoE4 profile.
###end p 60
###begin p 61
c Using the Markov chain approach (see text for details).
###end p 61
###begin p 62
d Using ApoE4 and Markov chain together.
###end p 62
###begin p 63
e Using the Markov chain approach did not significantly improve sample size.
###end p 63
###begin p 64
###xml 87 94 87 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
For comparison, the sample sizes based on rates of ADAS-Cog or MMSE are also listed in Table 3 for various study scenarios. In contrast to MRI, there was no benefit for sample size of ADAS-Cog and MMSE rates from using the Markov chain approach.
###end p 64
###begin title 65
Variability between MRI sites
###end title 65
###begin p 66
###xml 143 151 143 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 503 507 503 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 659 660 659 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 669 677 669 677 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5</label>
###xml 677 770 677 770 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="67">Variability in measuring hippocampal rates between MRI centres. Centres are coded by numbers.</p>
###xml 677 770 677 770 <caption xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="67">Variability in measuring hippocampal rates between MRI centres. Centres are coded by numbers.</p></caption>
###xml 770 770 770 770 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:href="awp007f5"/>
###xml 669 770 669 770 <fig xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="F5" position="float"><label>Figure 5</label><caption><p textid="67">Variability in measuring hippocampal rates between MRI centres. Centres are coded by numbers.</p></caption><graphic xlink:href="awp007f5"/></fig>
###xml 388 396 <span type="species:ncbi:9606">patients</span>
Lastly, we determined the extent to which MRI performed at multiple centres increases the variability compared with MRI at individual centres. Figure 5 depicts the variability of random effects errors in measurements of hippocampal rates between the centres. Data are shown for 13 MRI centres, which had MRI data collected at three time-points in at least seven mild cognitive impairment patients at the time this report was written. For comparison, the variability of random effects errors when all 47 ADNI centres were included is indicated by the black bar on the far right. Overall, variability of MRI performance between the centres was not significant (P = 0.5). Figure 5Variability in measuring hippocampal rates between MRI centres. Centres are coded by numbers.
###end p 66
###begin p 67
Variability in measuring hippocampal rates between MRI centres. Centres are coded by numbers.
###end p 67
###begin title 68
Discussion
###end title 68
###begin p 69
###xml 515 519 512 516 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 927 931 924 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 362 370 <span type="species:ncbi:9606">patients</span>
###xml 595 603 <span type="species:ncbi:9606">patients</span>
Our main findings are: (i) in mild cognitive impairment and Alzheimer's disease, progression of hippocampal loss was detected over 6 months and accelerated over 1 year, whereas in the normal group hippocampal loss was detected over 1 year with no indication of acceleration; (ii) ApoE4 was associated with higher rates of hippocampal loss in Alzheimer's disease patients, irrespective of their level of cognitive impairments; (iii) higher rates of hippocampal loss correlated with a lower concentration of CSF Abeta1-42, irrespective of ApoE genotype, predominantly in mild cognitive impairment patients. Furthermore, we showed that the power of measuring hippocampal change can be improved by exploiting intrinsic correlations between successive MRI observations. In addition, we showed that site-to-site variations in MRI can effectively be brought to levels similar to single site settings using the rigorous methods of the ADNI.
###end p 69
###begin p 70
###xml 238 244 238 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 250 251 250 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 246 251 246 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2008<italic>b</italic></xref>
###xml 952 958 952 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 969 975 969 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 977 981 977 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">2004</xref>
###xml 987 993 987 993 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 995 999 995 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">2005</xref>
###xml 1011 1017 1011 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1019 1023 1019 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">2005</xref>
###xml 1105 1111 1105 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1117 1118 1117 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 1113 1118 1113 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">2008<italic>b</italic></xref>
###xml 1131 1137 1131 1137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1139 1143 1139 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">2007</xref>
###xml 1254 1260 1254 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1266 1267 1266 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</italic>
###xml 1262 1267 1262 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">2008<italic>a</italic></xref>
###xml 1454 1460 1454 1460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1462 1466 1462 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">2000</xref>
###xml 2066 2070 2066 2070 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 2046 2058 <span type="species:ncbi:9606">participants</span>
We found significant hippocampal volume loss in mild cognitive impairment and Alzheimer's disease over only 6 months. All but one other MRI study reported hippocampal loss over such a short period and only for Alzheimer's disease (Barnes et al., 2008b). Furthermore, the prior study conducted MRI at a single centre only, yielding no conclusions for multicentre trials. Nonetheless, our results in Alzheimer's disease and those from this single centre study are intriguingly similar. Our results (average of 0-6 and 6-12 months rate values) expressed as percentage annual change yield 4.5% hippocampal loss in Alzheimer's disease (2-6% within 95% CI) compared with the range 4.35-5.04% that the single centre study reported. For mild cognitive impairment, our results over 6 months yield 2.5% annualized hippocampal loss (2.0-3.3% within 95% CI), in good agreement with reports of most other longitudinal MRI studies of mild cognitive impairment (Jack et al., 2000; Du et al., 2004; Fox et al., 2005; Hashimoto et al., 2005) that used much longer scan intervals, including two multicentre trials (Jack Jr et al., 2008b; van de Pol et al., 2007). The rates of hippocampal loss in our study are also within the range found in a large meta-analysis (Barnes et al., 2008a). It is furthermore re-affirming that our results obtained with a semi-automated method for tracing the hippocampus are comparable with those that employed entirely manual methods (Jack et al., 2000). Taken together, our results imply that an assessment of hippocampal loss over 6 months is possible and this extends to multicentre trials. However, measurement power is clearly sacrificed at shorter intervals as indicated by the larger standard errors for rates from measurements over 6 months compared to those over 12 months. Limited spatial resolution of MRI is likely the main reason for incurring errors at shorter scan intervals. Therefore, longitudinal studies of hippocampal loss should benefit from higher MRI resolution, if it can be afforded. Since a quarter of the participants in the ADNI will also be scanned at 3T parallel to 1.5T but at 20% higher resolution, the impact of image resolution on the power to measure brain volume loss can ultimately been tested. It is surprising that the rate of volume loss in mild cognitive impairment between 6 and 12 months is similar to that in Alzheimer's disease between 0 and 6 months, though some mild cognitive impairment subjects are destined to develop Alzheimer's disease. A possible explanation for this observation is that accelerated volume loss over time is a more prominent feature that separates Alzheimer's disease from mild cognitive impairment than constant volume loss. In addition, the annual percentage change from baseline is lower in mild cognitive impairment than in Alzheimer's disease.
###end p 70
###begin p 71
###xml 141 149 <span type="species:ncbi:9606">patients</span>
The rates of hippocampal loss also correlated with rates of cognitive decline. In general, Alzheimer's disease and mild cognitive impairment patients with high hippocampal rates also had rapidly increasing ADAS-Cog scores, while the correlation with MMSE scores was weaker. It is possible that cognitive tests that are more specific for hippocampal function show stronger correlations with MRI. Additional analyses that are beyond the scope of this report are warranted to further explore the cognitive correlates of hippocampal volume changes.
###end p 71
###begin p 72
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">2004</xref>
###xml 146 152 146 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">2005</xref>
###xml 165 171 165 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 173 177 173 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">2005</xref>
###xml 262 266 262 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">1993</xref>
###xml 274 280 274 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">1997</xref>
We also found significant hippocampal loss in the normal group over 1 year, in agreement with several prior MRI studies (Fox and Schott, 2004; Du et al., 2005; Jack et al., 2005) as well as with autopsy findings of neuronal loss in the ageing hippocampus (West, 1993; Simic et al., 1997). However, to determine if hippocampal loss in normal subjects is already an indication of incipient Alzheimer's disease or other pathologies affecting the hippocampus requires clinical follow-up of the subjects to determine their cognitive decline and ultimate development of Alzheimer's disease.
###end p 72
###begin p 73
###xml 231 237 231 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 243 244 243 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 239 244 239 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">2008<italic>c</italic></xref>
###xml 290 296 290 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 298 302 298 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">2006</xref>
###xml 438 444 438 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 446 450 446 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">2003</xref>
###xml 460 466 460 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 468 472 468 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">2008</xref>
###xml 595 601 595 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 603 607 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">2005</xref>
###xml 615 621 615 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 623 627 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">2006</xref>
###xml 863 867 863 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 1533 1537 1533 1537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
We found accelerated hippocampal loss in the mild cognitive impairment and Alzheimer's disease groups over a period of 1 year. Accelerated rates of hippocampal loss have previously been reported for mild cognitive impairment (Jack et al., 2008c) and for familial Alzheimer's disease (Ridha et al., 2006), but over periods that ranged from 2 to 5 years. Our finding is also consistent with reports of accelerated loss of whole brain (Chan et al., 2003; Carlson et al., 2008) and clinical studies of accelerated cognitive decline in mild cognitive impairment and early Alzheimer's disease (Mungas et al., 2005; Boyle et al., 2006). To estimate accelerated hippocampal loss, we used a simple quadratic expansion for change that may not accurately reflect the true progression of hippocampal loss. Observations at much more than three time- points, as planned in the ADNI, should help to better characterize the trajectory of accelerated loss. Nonetheless, the finding of accelerating hippocampal loss is important for understanding the natural history of Alzheimer's disease and emphasizes the need for early diagnosis and therapeutic intervention. The fact that we were able to detect accelerated rates over 1-year period has consequences for longitudinal MRI studies with only two time-points. First, such studies may overestimate or underestimate hippocampal loss rates since two serial measurements are indifferent to accelerations. Second, the ability to detect differences may be limited if accelerations vary among subjects. The ADNI is funded to scan each subject multiple times over 3 years to provide more information on longitudinal change.
###end p 73
###begin p 74
###xml 109 115 109 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">2000</xref>
###xml 129 135 129 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 137 141 137 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">2001</xref>
###xml 151 157 151 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 163 164 163 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 159 164 159 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">2008<italic>b</italic></xref>
###xml 177 183 177 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">2007</xref>
###xml 238 244 238 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 246 250 246 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">2000</xref>
###xml 366 372 366 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 378 379 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">b</italic>
###xml 374 379 374 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">2008<italic>b</italic></xref>
###xml 471 475 471 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 521 527 521 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 529 533 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">2008</xref>
###xml 1006 1012 1006 1012 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1014 1018 1014 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">2007</xref>
###xml 1623 1629 1607 1613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1631 1635 1615 1619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">2004</xref>
###xml 1644 1650 1628 1634 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1652 1656 1636 1640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">2005</xref>
###xml 1076 1084 <span type="species:ncbi:9606">patients</span>
###xml 1883 1891 <span type="species:ncbi:9606">patients</span>
Our finding that ApoE4 is a modulator of hippocampal loss rates is consistent with other MRI studies (Moffat et al., 2000; Cohen et al., 2001; Jack Jr et al., 2008b; van de Pol et al., 2007), but some studies found no ApoE effect (Laakso et al., 2000). Furthermore, whereas others reported an ApoE4 effect on hippocampal rates for mild cognitive impairment (Jack Jr et al., 2008b), we found it limited to Alzheimer's disease. In a recent cross-sectional MRI study of 676 ADNI subjects using tensor-based morphometry (Hua et al., 2008), over half of the Alzheimer's disease and mild cognitive impairment subjects carried the ApoE4 gene, and they showed greater hippocampal and temporal lobe deficits than non-carriers. Around one-sixth of the controls carried the protective ApoE2 gene and showed reduced ventricular expansion, perhaps reflecting a lesser degree of overall brain atrophy. We did not find a significant dose effect of ApoE4 on hippocampal loss rates in contrast to another study (van de Pol et al., 2007). Given our sample size of 226 mild cognitive impairment patients and approximately10% within subject variation, we should have been able to detect about 5% difference between carriers and non-carriers with 80% power and at alpha = 0.05 significance. One possible explanation for the discrepant ApoE findings in mild cognitive impairment is the notorious heterogeneity of this group, which-in absence of histological evidence for Alzheimer's disease pathology-may include other causes of cognitive complaints, such as mood disorders or cerebrovascular disease that both can impact the hippocampus (Lloyd et al., 2004; Mungas et al., 2005). Nonetheless, our finding suggests that presence of ApoE4 exacerbates the impact of Alzheimer's disease on the hippocampus. Alzheimer's disease cohorts of future therapeutic trials could be enriched by including specifically patients who carry ApoE4 and are likely to have small hippocampi and high rates of hippocampal loss.
###end p 74
###begin p 75
###xml 112 116 109 113 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 320 324 314 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 455 461 449 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 463 467 457 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">2003</xref>
###xml 478 484 472 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 486 490 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">2005</xref>
###xml 601 607 595 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 609 613 603 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">2003</xref>
###xml 707 711 698 702 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 795 801 786 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 803 807 794 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">2006</xref>
###xml 856 860 844 848 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 931 937 919 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 939 943 927 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">2008</xref>
###xml 1107 1113 1095 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1115 1119 1103 1107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">2006</xref>
###xml 1173 1177 1158 1162 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 1399 1405 1384 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 1407 1411 1392 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">2005</xref>
###xml 1638 1642 1620 1624 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 1741 1745 1720 1724 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 1902 1906 1878 1882 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 1967 1971 1940 1944 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1-42</sub>
###xml 2231 2237 2204 2210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2239 2243 2212 2216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">2003</xref>
###xml 2324 2328 2294 2298 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 2637 2643 2607 2613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 2645 2649 2615 2619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">2003</xref>
###xml 911 919 <span type="species:ncbi:9606">patients</span>
###xml 1516 1524 <span type="species:ncbi:9606">patients</span>
###xml 1690 1698 <span type="species:ncbi:9606">patients</span>
We also found a marked association between higher rates of hippocampal loss and decreased concentration of Abeta1-42 in CSF, predominantly in the mild cognitive impairment group, whereas for t-tau we found only a trend in the Alzheimer's disease group and for p-tau no significant association in any of the groups. Abeta1-42 and tau concentrations in CSF represent the earliest and most intensely studied biochemical markers of Alzheimer's disease (Frank et al., 2003; Grossman et al., 2005). How well these biomarkers reflect an autopsy-confirmed dementia diagnosis has intensely been studied (Clark et al., 2003). Both proteins are directly linked to the two hallmark lesions of Alzheimer's disease, Abeta1-42 with amyloid plaques and tau (t-tau and p-tau) with neurofibrillary tangles (Clark et al., 2006). Numerous studies have documented reduced Abeta1-42 and increased p-tau in CSF in Alzheimer's disease patients (see Clark et al., 2008 for review). But only two prior MRI studies compared CSF biomarkers with hippocampal loss rates in a small pool of subjects. Consistent with our findings, de Leon et al. (2006) reported greater hippocampal loss with greater Abeta1-42 decrease. In contrast to our results in mild cognitive impairment, they also found significantly greater hippocampal loss with increased p-tau but their study included only nine mild cognitive impairment subjects. Hampel et al. (2005), studying Alzheimer's disease, found increased hippocampal rates correlated with increased p-tau in 22 patients, while we found only a trend. Our finding that increased rates of hippocampal loss correlate with decreased Abeta1-42 in a large number of mild cognitive impairment patients is particularly interesting, because Abeta1-42 is directly related to Alzheimer's disease pathology. It is also important to note that the association between high hippocampal rates and reduced CSF Abeta1-42 was independent of the ApoE profile, implying that CSF Abeta1-42 levels and rates of hippocampal loss are directly linked. The results support the view that high rates of hippocampal loss in mild cognitive impairment indicate Alzheimer's disease pathology. Since the hippocampus is spared from early amyloid burden (Silbert et al., 2003), the correlation between high rates of hippocampal loss and decreased CSF Abeta1-42, further implies that the two measures provide complimentary information about the presence of Alzheimer's disease pathology. However, the diagnostic value of the measures used together remains unclear, because each measure can also change in other pathological conditions, such as Lewy body dementia (Clark et al., 2003).
###end p 75
###begin p 76
###xml 1346 1350 1346 1350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 1250 1258 <span type="species:ncbi:9606">patients</span>
Using a Markov chain model to analyse hippocampal change, we showed that intrinsic correlations between successive MRI observations exist and can be exploited to reduce within subject variability and consequently improve measurement power. The impact on power was substantial despite the fact that we performed hippocampal tracing independently for each time-point. The results imply that image processing algorithms that utilize correlations between observations, i.e. by using the hippocampal boundaries from past MRI scans as priors for tracing the boundaries in a new MRI scan, should be superior to those algorithms that do not employ priors. However, the approach also has limitations, as our results indicate. For instance, the Markov chain approach did not benefit the analysis of data from the normal group as much as the analysis of the mild cognitive impairment or Alzheimer's disease group, presumably because errors in assessing the small volume changes in normal subjects were random and dominated systematic biological changes. At the other end, the benefit of a Markov chain analysis was also less effective for Alzheimer's disease than for mild cognitive impairment data, presumably because the volume changes in Alzheimer's disease patients were sufficiently large to incur fewer errors to begin with. Since each subject in the ADNI study will ultimately have multiple successive MRI scans, it will be possible to evaluate the benefit of analysis using Markov chain models in more detail.
###end p 76
###begin p 77
###xml 157 161 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 659 665 659 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 902 908 902 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Fig. 5</xref>
###xml 1333 1337 1333 1337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 1615 1623 <span type="species:ncbi:9606">patients</span>
Our results demonstrate that for studies of hippocampal rates site-to-site variations in MRI can effectively be controlled using the rigorous methods of the ADNI. The result is important, because multiple MRI centre settings are indispensable for large studies, such as clinical trials with hundreds of subjects. Since additional variability is inevitably introduced in multiple MRI site settings compared to a single site setting, which is more common for investigational study use, we were also interested in comparing the powers of multisite and single site studies to detect a certain level of atrophy rates. Based on the site-to-site variations shown in Fig. 5, we estimated that 80% power of this multisite study of 47 MRI sites translates roughly into 87% power if the same study with the same population and number of subjects was conducted at the 'best' single MRI site in this study (#116 in Fig. 5) with the least variability of all sites. Although the result implies a benefit in power from a single site, as expected, the gain overall seems small, especially if one considers that the other participating sites in this study have smaller benefit margins since they show greater variability than the 'best' single site. In summary, the result attests to the effectiveness of the rigorous control methods developed by the ADNI. Our power estimations also show that MRI consistently provides greater power to measure progression than cognitive tests, such as ADAS-Cog or MMSE. Furthermore, some additional power can be gained by measuring hippocampal change at more time-points and by considering whether patients carry ApoE4.
###end p 77
###begin p 78
###xml 516 520 516 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 897 903 897 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al.</italic>
###xml 905 909 905 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">2000</xref>
Several limitations ought to be mentioned: First, mild cognitive impairment and normal subjects have not been followed long enough to determine the incidence of incipient Alzheimer's disease in each respective group. The rates and accelerations for these groups may therefore be biased toward higher values if many subjects with preclinical Alzheimer's disease were included. Furthermore, clinical criteria are always imperfect and some subjects in a mild stage of disease can be difficult to classify. However, the ADNI utilizes the rigorous diagnostic criteria of therapeutic trials which are one of the best available. The chance of a major bias of the results due to clinical misdiagnosis is small. Second, white matter lesions, an indication for cerebrovascular disease, were not accounted for. As previous studies showed white matter lesions can be associated with hippocampal atrophy (Fein et al., 2000), our results could at least in part be related to vascular disease. Third, since the algorithm to measure the hippocampus utilizes information from the rest of the brain, changes in other brain regions as well as image artefacts could have mimicked hippocampal variations. Completely manual measurements of the hippocampus might therefore lead to a different outcome.
###end p 78
###begin p 79
###xml 364 368 361 365 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1&#8211;42</sub>
###xml 106 114 <span type="species:ncbi:9606">patients</span>
In conclusion, the demonstration of hippocampal loss in mild cognitive impairment and Alzheimer's disease patients over 6 months and accelerated loss over 12 months illustrates the power of MRI to track morphological brain changes over time in a large multisite setting. Furthermore, our finding of higher hippocampal loss in presence of ApoE4 and reduced CSFAbeta1-42 supports the concept that increased hippocampal loss is an indicator of Alzheimer's disease pathology and a potential marker to assess therapeutic interventions in Alzheimer's disease.
###end p 79
###begin title 80
Supplementary material
###end title 80
###begin p 81
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Brain</italic>
 is available at Brain online.
###end p 81
###begin title 82
Funding
###end title 82
###begin p 83
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 900 904 900 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
###xml 1140 1169 1140 1169 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health</grant-sponsor>
###xml 1171 1183 1171 1183 <grant-num xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U01 AG024904</grant-num>
The ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering (NIBIB), and through generous contributions from the following: Pfizer Inc., Wyeth Research, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Merck & Co. Inc., AstraZeneca AB, Novartis Pharmaceuticals Corporation, Alzheimer's Association, Eisai Global Clinical Development, Elan Corporation plc, Forest Laboratories, Innogenetics, NV, Ghent, Belgium, and the Institute for the Study of Aging, with participation from the U.S. Food and Drug Administration. Industry partnerships are coordinated through the Foundation for the National Institutes of Health. The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. The ADNI data are disseminated by the Laboratory of Neuro Imaging at the University of California, Los Angeles. Funding to pay the Open Access publication charges for this article was provided by the Alzheimer's Disease Neuroimaging Initiative National Institutes of Health (U01 AG024904 to M.W.).
###end p 83
###begin title 84
Supplementary Material
###end title 84
###begin title 85
[Supplementary Data]
###end title 85
###begin title 86
Acknowledgements
###end title 86
###begin p 87
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
We are indebted to Drs Laurel Beckett, UC San Diego, Danielle Harvey, UC Davis and John Kornak, UC San Francisco for statistical support. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI; Principal Investigator: M.W.).
###end p 87
###begin title 88
References
###end title 88
###begin article-title 89
A meta-analysis of hippocampal atrophy rates in Alzheimer's disease
###end article-title 89
###begin article-title 90
Increased hippocampal atrophy rates in Alzheimer's disease over 6 months using serial MR imaging
###end article-title 90
###begin article-title 91
Mild cognitive impairment: risk of Alzheimer disease and rate of cognitive decline
###end article-title 91
###begin article-title 92
Evolution of neuronal changes in the course of Alzheimer's disease
###end article-title 92
###begin article-title 93
Trajectories of brain loss in aging and the development of cognitive impairment
###end article-title 93
###begin article-title 94
Change in rates of cerebral atrophy over time in early-onset Alzheimer's disease: longitudinal MRI study
###end article-title 94
###begin article-title 95
Volumetric transformation of brain anatomy
###end article-title 95
###begin article-title 96
Biomarkers for early detection of Alzheimer pathology
###end article-title 96
###begin article-title 97
Biochemical biomarkers of late-life dementia
###end article-title 97
###begin article-title 98
Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?
###end article-title 98
###begin article-title 99
###xml 80 85 <span type="species:ncbi:9606">women</span>
Effect of apolipoprotein E genotype on hippocampal volume loss in aging healthy women
###end article-title 99
###begin article-title 100
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment
###end article-title 100
###begin article-title 101
White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy
###end article-title 101
###begin article-title 102
Higher atrophy rate of entorhinal cortex than hippocampus in Alzheimer's disease
###end article-title 102
###begin article-title 103
Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease [In Process Citation]
###end article-title 103
###begin article-title 104
Global prevalence of dementia: a Delphi consensus study
###end article-title 104
###begin article-title 105
###xml 117 125 <span type="species:ncbi:9606">patients</span>
Morphometric changes in the episodic memory network and tau pathologic features correlate with memory performance in patients with mild cognitive impairment
###end article-title 105
###begin article-title 106
###xml 75 83 <span type="species:ncbi:9606">patients</span>
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician
###end article-title 106
###begin article-title 107
Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease
###end article-title 107
###begin article-title 108
Imaging cerebral atrophy: normal ageing to Alzheimer's disease
###end article-title 108
###begin article-title 109
Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease
###end article-title 109
###begin article-title 110
Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease
###end article-title 110
###begin article-title 111
Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease
###end article-title 111
###begin article-title 112
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?
###end article-title 112
###begin article-title 113
Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia
###end article-title 113
###begin article-title 114
Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: An MRI study of 676 Alzheimer's disease, mild cognitive impairment, and normal subjects
###end article-title 114
###begin article-title 115
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADNI</italic>
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods
###end article-title 115
###begin article-title 116
Longitudinal MRI findings from the vitamin E and Donepezil treatment study for mild cognitive impairment
###end article-title 116
###begin article-title 117
Rates of hippocampal atrophy correlate with change in clinical status in aging and Alzheimer's disease
###end article-title 117
###begin article-title 118
Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic mild cognitive impairment
###end article-title 118
###begin article-title 119
Atrophy rates accelerate in amnestic mild cognitive impairment
###end article-title 119
###begin article-title 120
Rates of Hippocampal Atrophy in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease
###end article-title 120
###begin article-title 121
Comparison of different MRI brain atrophy rate measures with clinical disease progression in Alzheimer's disease
###end article-title 121
###begin article-title 122
MRI as a Biomarker of Disease Progression in a Therapeutic Trial of Milameline fo Alzheimer's
###end article-title 122
###begin article-title 123
Hippocampus in Alzheimer's disease: a 3-year follow-up MRI study
###end article-title 123
###begin article-title 124
Longitudinal stability of MRI for mapping brain change using tensor-based morphometry
###end article-title 124
###begin article-title 125
Hippocampal volume change in depression: late- and early-onset illness compared
###end article-title 125
###begin article-title 126
###xml 146 151 <span type="species:ncbi:9606">Human</span>
Clinical diagnosis of Alzheimer's disease: report of the NINCDS- Alzheimer's diseaseRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
###end article-title 126
###begin article-title 127
Longitudinal change in hippocampal volume as a function of apolipoprotein E genotype
###end article-title 127
###begin article-title 128
Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study
###end article-title 128
###begin article-title 129
The Clinical Dementia Rating (CDR): current version and scoring rules [see comments]
###end article-title 129
###begin article-title 130
The Alzheimer's disease neuroimaging initiative
###end article-title 130
###begin article-title 131
Longitudinal volumetric MRI change and rate of cognitive decline
###end article-title 131
###begin article-title 132
Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study
###end article-title 132
###begin article-title 133
Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics
###end article-title 133
###begin article-title 134
Cerebrospinal fluid biomarker signature in Alzheimer's Disease Neuroimaging Initiative (ADNI) subjects
###end article-title 134
###begin article-title 135
Changes in premorbid brain volume predict Alzheimer's disease pathology
###end article-title 135
###begin article-title 136
###xml 36 41 <span type="species:ncbi:9606">human</span>
Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease
###end article-title 136
###begin article-title 137
Tracking Alzheimer's disease
###end article-title 137
###begin article-title 138
Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease
###end article-title 138
###begin article-title 139
Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment
###end article-title 139
###begin article-title 140
Alzheimer's disease biomarkers: From concept to clinical utility
###end article-title 140
###begin article-title 141
###xml 49 54 <span type="species:ncbi:9606">human</span>
Regionally specific loss of neurons in the aging human hippocampus
###end article-title 141
###begin article-title 142
Development and validation of a geriatric depression screening scale: a preliminary report
###end article-title 142
###begin title 143
Abbreviations
###end title 143
###begin p 144
Alzheimer's disease Assessment Scale-Cognitive Subscale
###end p 144
###begin p 145
Alzheimer's Disease Neuroimaging Initiative
###end p 145
###begin p 146
apolipoprotein E
###end p 146
###begin p 147
Clinical Dementia Rating
###end p 147
###begin p 148
cerebrospinal fluid
###end p 148

